<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plospath</journal-id>
<journal-title-group>
<journal-title>PLOS Pathogens</journal-title>
</journal-title-group>
<issn pub-type="ppub">1553-7366</issn>
<issn pub-type="epub">1553-7374</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.ppat.1005924</article-id>
<article-id pub-id-type="publisher-id">PPATHOGENS-D-16-01029</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject><subj-group><subject>Cytotoxic T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Blood cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>White blood cells</subject><subj-group><subject>T cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Neck</subject><subj-group><subject>Throat</subject><subj-group><subject>Tonsils</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Neck</subject><subj-group><subject>Throat</subject><subj-group><subject>Tonsils</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>HIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Animals</subject><subj-group><subject>Vertebrates</subject><subj-group><subject>Amniotes</subject><subj-group><subject>Mammals</subject><subj-group><subject>Primates</subject><subj-group><subject>Monkeys</subject><subj-group><subject>Old World monkeys</subject><subj-group><subject>Macaque</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Model organisms</subject><subj-group><subject>Animal models</subject><subj-group><subject>Rhesus monkeys</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Animals</subject><subj-group><subject>Vertebrates</subject><subj-group><subject>Amniotes</subject><subj-group><subject>Mammals</subject><subj-group><subject>Primates</subject><subj-group><subject>Monkeys</subject><subj-group><subject>Old World monkeys</subject><subj-group><subject>Macaque</subject><subj-group><subject>Rhesus monkeys</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>HIV infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>SIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>SIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>SIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Immunodeficiency viruses</subject><subj-group><subject>SIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>SIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>SIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>SIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Retroviruses</subject><subj-group><subject>Lentivirus</subject><subj-group><subject>SIV</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and <italic>Ex Vivo</italic> HIV Infection</article-title>
<alt-title alt-title-type="running-head">Follicular CD8 Treg in HIV Infection</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5670-4432</contrib-id>
<name name-style="western">
<surname>Miles</surname>
<given-names>Brodie</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Miller</surname>
<given-names>Shannon M.</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Folkvord</surname>
<given-names>Joy M.</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Levy</surname>
<given-names>David N.</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Rakasz</surname>
<given-names>Eva G.</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3388-1687</contrib-id>
<name name-style="western">
<surname>Skinner</surname>
<given-names>Pamela J.</given-names>
</name>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Connick</surname>
<given-names>Elizabeth</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Division of Infectious Diseases, Anschutz Medical Campus, University of Colorado Denver, Colorado, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Immunology and Microbiology, School of Medicine, Anschutz Medical Campus, University of Colorado Denver, Colorado, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Division of Infectious Diseases, University of Arizona, Arizona, United States of America</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Basic Science, New York University College of Dentistry, New York, United States of America</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Wisconsin National Primate Research Center, University of Wisconsin-Madison, Wisconsin, United States of America</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>Department of Veterinary and Biomedical Sciences, University of Minnesota, Minnesota, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Silvestri</surname>
<given-names>Guido</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Emory University, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p>
<list list-type="simple">
<list-item><p><bold>Conceptualization:</bold> BM SMM PJS EC.</p></list-item>
<list-item><p><bold>Formal analysis:</bold> BM SMM EC.</p></list-item>
<list-item><p><bold>Funding acquisition:</bold> PJS EC.</p></list-item>
<list-item><p><bold>Investigation:</bold> BM SMM JMF.</p></list-item>
<list-item><p><bold>Methodology:</bold> BM SMM JMF DNL EGR.</p></list-item>
<list-item><p><bold>Resources:</bold> DNL EGR PJS.</p></list-item>
<list-item><p><bold>Supervision:</bold> EC.</p></list-item>
<list-item><p><bold>Validation:</bold> BM SMM EC.</p></list-item>
<list-item><p><bold>Writing – original draft:</bold> BM SMM EC.</p></list-item>
<list-item><p><bold>Writing – review &amp; editing:</bold> BM SMM EC.</p></list-item>
</list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">connicke@email.arizona.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>7</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>10</month>
<year>2016</year>
</pub-date>
<volume>12</volume>
<issue>10</issue>
<elocation-id>e1005924</elocation-id>
<history>
<date date-type="received">
<day>9</day>
<month>5</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>9</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Miles et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.ppat.1005924"/>
<abstract>
<p>During chronic HIV infection, viral replication is concentrated in secondary lymphoid follicles. Cytotoxic CD8 T cells control HIV replication in extrafollicular regions, but not in the follicle. Here, we show CXCR5<sup>hi</sup>CD44<sup>hi</sup>CD8 T cells are a regulatory subset differing from conventional CD8 T cells, and constitute the majority of CD8 T cells in the follicle. This subset, CD8 follicular regulatory T cells (CD8 T<sub>FR</sub>), expand in chronic SIV infection, exhibit enhanced expression of Tim-3 and IL-10, and express less perforin compared to conventional CD8 T cells. CD8 T<sub>FR</sub> modestly limit HIV replication in follicular helper T cells (T<sub>FH</sub>), impair T<sub>FH</sub> IL-21 production via Tim-3, and inhibit IgG production by B cells during <italic>ex vivo</italic> HIV infection. CD8 T<sub>FR</sub> induce T<sub>FH</sub> apoptosis through HLA-E, but induce less apoptosis than conventional CD8 T cells. These data demonstrate that a unique regulatory CD8 population exists in follicles that impairs GC function in HIV infection.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author Summary</title>
<p>HIV is a chronic infection and is never completely cleared from the body, despite successful antiretroviral therapy that reduces plasma viral loads to undetectable levels and restores CD4 T cell counts. While undetectable in plasma, HIV is able to hide in various niches throughout the body. One such niche are CD4 T cells residing in the follicles and germinal centers of secondary lymphoid tissues. The dynamics of these regions that lead to persistence of HIV-infected cells remain unclear. However, recent evidence strongly suggests that CD8 cytotoxic T lymphocytes, which are able to kill HIV-infected cells outside of these regions, are present at low numbers in follicles and germinal centers. Here, we further advance these recent findings by showing that the few CD8 T cells within the follicle have potent regulatory functions rather than conventional cytotoxic functions. Thus, the CD8 T cells entering these regions of HIV persistence not only fail to kill HIV-infected cells, but promote impairments in humoral immunity. These findings identify a new obstacle that must be taken into account to improve immune responses and clearance of HIV.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AI096966</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Connick</surname>
<given-names>Elizabeth</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AI007447</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5670-4432</contrib-id>
<name name-style="western">
<surname>Miles</surname>
<given-names>Brodie</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AI007405</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Miller</surname>
<given-names>Shannon M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AI096966</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3388-1687</contrib-id>
<name name-style="western">
<surname>Skinner</surname>
<given-names>Pamela J.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award005">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AI078783A</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Levy</surname>
<given-names>David N.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award006">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>P51OD011106</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Rakasz</surname>
<given-names>Eva G.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award007">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>P30CA046934</award-id>
</award-group>
<award-group id="award008">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>P30AR057212</award-id>
</award-group>
<award-group id="award009">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
<institution>National Institute of Allergy and Infectious Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>HHSN272201300006C</award-id>
</award-group>
<award-group id="award010">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>R25OD010487</award-id>
</award-group>
<funding-statement>This work was funded by NIH/NIAID grants R01 AI096966 to EC and PJS, R01 AI078783A to DNL, T32 AI007447-22 to BM, T32 AI007405 to SMM, the Wisconsin National Primate Research Center (WNPRC) P51OD011106, and the Tim Gill Fund and the University of Colorado Denver Division of Infectious Diseases. Cell sorting was performed by the University of Colorado Cancer Flow Cytometry Shared Resource, which is supported by the Cancer Center Support Grant P30CA046934 and the Skin Diseases Research Cores Grant P30AR057212. Immunofluorescent data were acquired with the help of Gemma Parra from the University of Arizona Translating Translation and Scientific Questioning in the Global K-12 Community Program funded by NIH Grant #R25OD010487. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="8"/>
<table-count count="0"/>
<page-count count="25"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>In chronic HIV and SIV infection, viral replication is concentrated in B cell follicles in secondary lymphoid tissues [<xref ref-type="bibr" rid="ppat.1005924.ref001">1</xref>–<xref ref-type="bibr" rid="ppat.1005924.ref005">5</xref>], although factors that promote this are not fully understood. Follicular helper T cells (T<sub>FH</sub>), which reside in the secondary lymphoid follicles, are highly permissive to HIV [<xref ref-type="bibr" rid="ppat.1005924.ref006">6</xref>] and exhibit anti-apoptotic properties [<xref ref-type="bibr" rid="ppat.1005924.ref007">7</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref008">8</xref>] which likely contributes to viral persistence. We have previously shown that virus-specific CD8 T cells are present at lower frequencies inside the follicle compared to outside the follicle in HIV and SIV infection [<xref ref-type="bibr" rid="ppat.1005924.ref002">2</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref009">9</xref>], which may contribute to impaired viral clearance in the follicle. While CD8 T cells are present in the follicle, little is known about the function of these cells. We have previously reported that CD4 follicular regulatory T cells (T<sub>FR</sub>) are increased in number, exhibit heighted regulatory capabilities, and impair T<sub>FH</sub> proliferation and function in <italic>ex vivo</italic> HIV and <italic>in vivo</italic> SIV infection [<xref ref-type="bibr" rid="ppat.1005924.ref007">7</xref>]. We hypothesized that follicular CD8 T cells may also have regulatory functions that further contribute to immune dysregulation in chronic HIV infection.</p>
<p>Regulatory CD4 T cell populations can be readily identified based on expression of CD25 [<xref ref-type="bibr" rid="ppat.1005924.ref010">10</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref011">11</xref>], and Foxp3 [<xref ref-type="bibr" rid="ppat.1005924.ref012">12</xref>], their canonical transcription factor. Nevertheless, a consensus phenotype for CD8 Tregs has yet to be described. CD8 Tregs in the thymus and periphery of mice do not constitutively express Foxp3 [<xref ref-type="bibr" rid="ppat.1005924.ref012">12</xref>], and Foxp3-expressing CD8 T cells do not encompass CD8 Treg populations [<xref ref-type="bibr" rid="ppat.1005924.ref013">13</xref>]. CD8 Tregs have been described in humans, but have limited defining characteristics, and most lack Foxp3 [<xref ref-type="bibr" rid="ppat.1005924.ref014">14</xref>]. Thus, it is essential to demonstrate regulatory function with any CD8 Treg phenotype [<xref ref-type="bibr" rid="ppat.1005924.ref015">15</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref016">16</xref>].</p>
<p>In mice, CD8 Treg function is dependent on B and T lymphocyte expression of Qa-1, the murine equivalent of HLA-E, which binds to the TCR of CD8 T cells [<xref ref-type="bibr" rid="ppat.1005924.ref017">17</xref>–<xref ref-type="bibr" rid="ppat.1005924.ref019">19</xref>]; CD8 Treg function correlates with the affinity and duration of this interaction [<xref ref-type="bibr" rid="ppat.1005924.ref018">18</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref020">20</xref>]. A specific subset of CXCR5<sup>hi</sup>CD44<sup>hi</sup> CD8 Tregs (henceforth defined as CD8 T<sub>FR</sub> in this work) was found to limit germinal center (GC) size and prevent autoimmune disease in mice [<xref ref-type="bibr" rid="ppat.1005924.ref019">19</xref>]. The main targets of CD8 T<sub>FR</sub> are CD4 T cells [<xref ref-type="bibr" rid="ppat.1005924.ref017">17</xref>], specifically T<sub>FH</sub> [<xref ref-type="bibr" rid="ppat.1005924.ref019">19</xref>]. In autoimmune-prone mice, CD8 T<sub>FR</sub> limit T<sub>FH</sub> expansion and autoantibody production [<xref ref-type="bibr" rid="ppat.1005924.ref021">21</xref>]. CD8 T<sub>FR</sub> expressing CD122 (IL-2Rβ) in mice were also shown to inhibit CD8 T cell function through a mechanism involving IL-10 production, but not requiring TGFβ [<xref ref-type="bibr" rid="ppat.1005924.ref022">22</xref>]. CD8 T<sub>FR</sub> differ from conventional CD8 T cells in their potent suppressive mechanisms and their dependence on IL-15 for function [<xref ref-type="bibr" rid="ppat.1005924.ref019">19</xref>]. Importantly, cells with the CD8 T<sub>FR</sub> phenotype (CXCR5<sup>hi</sup>CD44<sup>hi</sup> CD8+) have recently been identified in humans [<xref ref-type="bibr" rid="ppat.1005924.ref023">23</xref>].</p>
<p>In the context of HIV infection there is limited evidence of CD8 Tregs. Stimulation of CD8 T cells isolated from HIV-infected patients with HIV peptides was shown to drive regulatory CD8 T cell function [<xref ref-type="bibr" rid="ppat.1005924.ref024">24</xref>]. Suppressive function of HIV-specific CD8 T cells was further shown to be dependent on IL-10 production [<xref ref-type="bibr" rid="ppat.1005924.ref025">25</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref026">26</xref>]. These HIV-specific CD8 T cells that produced IL-10 lacked both CD25 and Foxp3, but were able to prevent HIV-specific cytolytic function [<xref ref-type="bibr" rid="ppat.1005924.ref026">26</xref>]. Tim-3 has been previously shown to mediate CD4 Treg suppression [<xref ref-type="bibr" rid="ppat.1005924.ref027">27</xref>] and impair virus-specific CD8 T cell responses [<xref ref-type="bibr" rid="ppat.1005924.ref028">28</xref>]. CD8 T cells co-expressing PD-1 and Tim-3 have both exhausted effector function and produce high levels of IL-10 during chronic viral infection [<xref ref-type="bibr" rid="ppat.1005924.ref029">29</xref>]. Upregulation of Tim-3 on CTL is strongly correlated with reduced cytotoxicity [<xref ref-type="bibr" rid="ppat.1005924.ref030">30</xref>] and viral persistence [<xref ref-type="bibr" rid="ppat.1005924.ref031">31</xref>]. Additionally, Tim-3+ CD8 T cells were increased in frequency and positively correlated with plasma viral load in progressive HIV infection [<xref ref-type="bibr" rid="ppat.1005924.ref032">32</xref>]. Increased frequencies of CD8 T cells are also found in follicles of HIV-infected individuals compared to seronegative individuals [<xref ref-type="bibr" rid="ppat.1005924.ref001">1</xref>], but little is known about their functional properties. No studies to date have evaluated CD8 T<sub>FR</sub> in HIV or SIV infection and their potential role in HIV replication and persistence.</p>
<p>In this study, we describe CD8 T<sub>FR</sub> phenotype and function in secondary lymphoid tissues during <italic>ex vivo</italic> HIV infection of human tonsils and <italic>in vivo</italic> SIV infection. We define CD8 T<sub>FR</sub> as CD3+CD8+CXCR5<sup>hi</sup>CD44<sup>hi</sup> cells and find that most follicular CD8 T cells in human and rhesus macaque secondary lymphoid tissues are CD8 T<sub>FR</sub>. CD8 T<sub>FR</sub> exhibit an enhanced regulatory phenotype in the context of <italic>ex vivo</italic> HIV infection and chronic SIV infection and are expanded in chronic SIV infection. In contrast to conventional CD8 T cells, CD8 T<sub>FR</sub> are able to impair T<sub>FH</sub> effector function via Tim-3 and inhibit GC B cell IgG production. Further, CD8 T<sub>FR</sub> modestly reduce HIV replication in T<sub>FH</sub> and induce less T<sub>FH</sub> apoptosis than conventional CD8 T cells in HIV infection <italic>ex vivo</italic>. Induction of T<sub>FH</sub> apoptosis by CD8 T<sub>FR</sub> is dependent on HLA-E. This work provides the first functional analysis of follicular CD8 T cell populations in the context of lentiviral infections and suggests that CD8 T<sub>FR</sub> contribute to impaired T<sub>FH</sub> function and GC dysfunction during HIV infection.</p>
</sec>
<sec id="sec002" sec-type="results">
<title>Results</title>
<sec id="sec003">
<title>Characterization of CD8 T<sub>FR</sub> in ex vivo HIV-infected tonsils</title>
<p>First, we determined the fraction of follicular CD8 T cells within human tonsils that exhibit a CD8 T<sub>FR</sub> phenotype two days following spinoculation with X4- or R5-tropic GFP reporter virus or mock spinoculation. CD8 T<sub>FR</sub> are defined as viable CD3+CD8+CXCR5<sup>hi</sup>CD44<sup>hi</sup> cells and conventional CD8 T cells (CD8 conv) defined as all other CD3+CD8+ cells as shown in representative flow cytometry plots in <xref ref-type="fig" rid="ppat.1005924.g001">Fig 1A</xref>. The percentages of CD8 T<sub>FR</sub> are not significantly altered 2 days after HIV spinoculation compared to mock-spinoculated cells (<xref ref-type="fig" rid="ppat.1005924.g001">Fig 1B</xref>). Using flow cytometry counting beads to show the average of 3 experiments, we confirmed that CD8 T<sub>FR</sub> did not increase numerically in the context of <italic>ex vivo</italic> HIV infection (<xref ref-type="supplementary-material" rid="ppat.1005924.s001">S1 Fig</xref>). Additionally, we confirmed that percentages of CD8 T cells that are CD8 T<sub>FR</sub> do not differ between day 0, prior to any spinoculation or cell culture, and day 2 following mock spinoculation and 2 days in culture media (<xref ref-type="supplementary-material" rid="ppat.1005924.s002">S2 Fig</xref>).</p>
<fig id="ppat.1005924.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005924.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Human tonsil CD8 T<sub>FR</sub> are distinct from conventional CD8 T cells.</title>
<p>Disaggregated tonsil cell cultures were mock-spinoculated or spinoculated with X4- or R5-tropic HIV and cultured for 2 days (n = 8). (A) Flow gating strategy to determine viable, CD8 T<sub>FR</sub> (CD3+CD8+CXCR5<sup>hi</sup>CD44<sup>hi</sup>) and all other CD3+CD8+ cells (CD8 conv). (B) The percentage of CD8 T<sub>FR</sub> in mock- or HIV-spinoculated samples. The percent or MFI of CD8 T<sub>FR</sub> and CD8 conv expressing (C) Tim-3, (D) perforin, (E) IL-10, (F) IL-15 receptor, (G) GITR, and (H) CD122 (IL-2Rβ). Graphs depict median and range. Statistical significance was determined by non-parametric one-way ANOVA (Friedman test) and is displayed as * = p&lt;0.05 and ** = p&lt;0.01.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.g001" xlink:type="simple"/>
</fig>
<p>Next, we analyzed CD8 regulatory and exhaustion molecules (Tim-3, CD122, IL-15R, and IL-10), the CD4 Treg mediator GITR [<xref ref-type="bibr" rid="ppat.1005924.ref033">33</xref>], and perforin expression on CD8 T<sub>FR</sub> and CD8 conv in the of context HIV infection <italic>ex vivo</italic>. First, there are no significant differences in CD122, IL-10 or perforin expression in CD8 T<sub>FR</sub> between day 0 and day 2 in mock-spinoculated cultures (<xref ref-type="supplementary-material" rid="ppat.1005924.s002">S2 Fig</xref>). Tim-3 is expressed on a significantly greater percentage of CD8 T<sub>FR</sub> compared to CD8 conv in all culture conditions (i.e., mock-, X4-, and R5-spinoculated cultures) and there are no differences related to HIV infection (<xref ref-type="fig" rid="ppat.1005924.g001">Fig 1C</xref>). Perforin expression is lower in CD8 T<sub>FR</sub> compared to CD8 conv in all culture conditions, and is not altered by spinoculation (<xref ref-type="fig" rid="ppat.1005924.g001">Fig 1D</xref>). The percentage of IL-10+ CD8 T<sub>FR</sub> is significantly higher following both X4- and R5-spinoculation compared to mock-spinoculated cultures, and is significantly higher than the percentage of IL-10+ CD8 conv in each condition (<xref ref-type="fig" rid="ppat.1005924.g001">Fig 1E</xref>). X4- and R5-spinoculation leads to significantly higher percentages of IL-15R+ CD8 T<sub>FR</sub> compared to mock spinoculation, and there are greater percentages of IL-15R+ CD8 T<sub>FR</sub> compared to IL-15R+ CD8 conv after HIV spinoculation (<xref ref-type="fig" rid="ppat.1005924.g001">Fig 1F</xref>). The percentage of GITR+ CD8 T<sub>FR</sub> does not increase after HIV spinoculation, but the frequency of GITR+ CD8 T<sub>FR</sub> is greater than the frequency of GITR+ CD8 conv in all conditions (<xref ref-type="fig" rid="ppat.1005924.g001">Fig 1G</xref>). CD122 is expressed on a greater percentage of CD8 T<sub>FR</sub> after X4-spinoculation compared to mock-spinoculation, and is expressed on a greater percentage of CD8 T<sub>FR</sub> compared to CD8 conv in all conditions (<xref ref-type="fig" rid="ppat.1005924.g001">Fig 1H</xref>). There are not high levels of or significant differences in expression of the exhaustion molecule PD-1 or the inhibitory CD4 Treg receptor CTLA-4 between CD8 T<sub>FR</sub> and conventional CD8 T cells (<xref ref-type="supplementary-material" rid="ppat.1005924.s003">S3A Fig</xref>). Further, a majority of CD8 T<sub>FR</sub> have an effector memory as opposed to central memory profile, and express more IL-10, CD122, and GITR and less perforin than conventional CD8 T cells regardless of effector or central memory cell designation (<xref ref-type="supplementary-material" rid="ppat.1005924.s003">S3B Fig</xref>).</p>
</sec>
<sec id="sec004">
<title>The majority of CD8 T cells with a follicular homing phenotype are CD8 T<sub>FR</sub></title>
<p>Downregulation of CCR7, the extrafollicular retention molecule, combined with upregulation of CXCR5, the follicular homing molecule, is crucial for migration of CD4 T cells into follicles [<xref ref-type="bibr" rid="ppat.1005924.ref034">34</xref>]. It has previously been shown in human tonsils that CXCR5+CD8+ T cells were located in the follicles of human tonsils by immunofluorescent tissue staining [<xref ref-type="bibr" rid="ppat.1005924.ref035">35</xref>]. We determined the phenotype of CD8 T cells expressing the follicular homing phenotype CXCR5+CCR7- after mock-, X4-, and R5-spinoculation of human tonsil cells. A median of more than 90% of CXCR5+CCR7- cells are CD8 T<sub>FR</sub> in all conditions whereas only a minority of CD8 conv exhibit a follicular homing phenotype (<xref ref-type="fig" rid="ppat.1005924.g002">Fig 2A</xref>). We further analyzed CCR7 expression on both CD8 T<sub>FR</sub> and CD8 conv. The percent of CCR7 positive cells is significantly higher in CD8 conv than CD8 T<sub>FR</sub> (<xref ref-type="fig" rid="ppat.1005924.g002">Fig 2B</xref>).</p>
<fig id="ppat.1005924.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005924.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Most human tonsil follicular homing CD8 T cells are CD8 T<sub>FR</sub>.</title>
<p>Disaggregated tonsil cell cultures were mock-spinoculated or spinoculated with X4- or R5-tropic HIV and cultured for 2 days (n = 6). (A) Of the viable CD3+CD8+ population expressing the follicular phenotype CXCR5+CCR7-, the percent CD44<sup>hi</sup> (CD8 T<sub>FR</sub>) and all other CD3+CD8+ (CD8 conv) in mock- and HIV-spinoculated cultures is shown. (B) The percent CCR7 expression on CD8 T<sub>FR</sub> (red) and CD8 conv (blue) compared to an FMO control (black). Graphs depict median and range. Statistical significance was determined by non-parametric one-way ANOVA (Friedman test) and is displayed as * = p&lt;0.05.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec005">
<title>CD8 T<sub>FR</sub> inhibit T<sub>FH</sub> and IgG production in HIV infection <italic>ex vivo</italic></title>
<p>We next investigated whether CD8 T<sub>FR</sub> are able to suppress the GC reaction by inhibiting T<sub>FH</sub> proliferation and cytokine production, B cell function, or both. T cell proliferation is dependent on IL-2, and IL-21 production by T<sub>FH</sub> is critical for B cell affinity maturation in the GC [<xref ref-type="bibr" rid="ppat.1005924.ref036">36</xref>]. We therefore determined whether CD8 T<sub>FR</sub> inhibit IL-2 and IL-21 production by T<sub>FH</sub>. As whole tonsil cells were spinoculated for the data generated in Figs <xref ref-type="fig" rid="ppat.1005924.g001">1</xref> and <xref ref-type="fig" rid="ppat.1005924.g002">2</xref>, all sorted populations were spinoculated to mirror previous conditions and allow exposure to HIV. We find that CD8 T<sub>FR</sub> inhibit both IL-2 (<xref ref-type="supplementary-material" rid="ppat.1005924.s004">S4A Fig</xref>) and IL-21 (<xref ref-type="fig" rid="ppat.1005924.g003">Fig 3A</xref>) production by T<sub>FH</sub> in sorted X4- and R5-spinoculated cultures. This inhibition is dose-dependent on the ratio of CD8 T<sub>FR</sub> to T<sub>FH</sub> and does not occur when T<sub>FH</sub> are cultured with CD8 conv (<xref ref-type="supplementary-material" rid="ppat.1005924.s004">S4B Fig</xref>). To investigate potential mechanisms regulating IL-21 production in T<sub>FH</sub>, we blocked Tim-3 in 1:1 CD8 T<sub>FR</sub>:T<sub>FH</sub> co-cultures. Blockade of Tim-3 abrogates the effect of CD8 T<sub>FR</sub> and preserves the percent of IL-21+ T<sub>FH</sub> at levels similar to T<sub>FH</sub> cultured alone (representative examples: <xref ref-type="fig" rid="ppat.1005924.g003">Fig 3B</xref>, all data and 3C), but this is not observed in T<sub>FH</sub> and CD8 T<sub>FR</sub> co-culture with isotype control antibodies (<xref ref-type="fig" rid="ppat.1005924.g003">Fig 3B and 3C</xref>) or T<sub>FH</sub> and CD8 conv co-cultures (<xref ref-type="supplementary-material" rid="ppat.1005924.s004">S4C Fig</xref>). There is not a consistent trend in alteration of T<sub>FH</sub> proliferation rates, as determined by proliferation dye dilution, in the presence of CD8 T<sub>FR</sub> when cultured at a 1:1 ratio (<xref ref-type="supplementary-material" rid="ppat.1005924.s005">S5 Fig</xref>).</p>
<fig id="ppat.1005924.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005924.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Human tonsil CD8 T<sub>FR</sub> inhibit T<sub>FH</sub> and GC B cell function.</title>
<p>Tonsil cells were sorted to isolate CD8 T<sub>FR</sub>, CD8 conv, CD3+CD8-CXCR5+ T<sub>FH</sub>, and CD19+CD38+ GC B cells and X4- or R5-spinoculated. Cells were then co-cultured at indicated ratios for 2 days and analyzed. (A) IL-21 production by T<sub>FH</sub> with increasing (left to right) number of CD8 T<sub>FR</sub> (n = 4). (B) Representative examples from X4- and R5-spinoculations showing IL-21 production by T<sub>FH</sub> alone, 1:1 with CD8 T<sub>FR</sub>, 1:1 with CD8 T<sub>FR</sub> and anti-Tim3 antibody (500 ng/μl; right panels), and 1:1 with CD8 T<sub>FR</sub> and an isotype control antibody (500 ng/μl). (C) Results from a total of 6 tonsils (isotype n = 3) as described in B. (D) IgG production in X4-spinoculated cultures with 2.5 μg/mL CpG-B stimulation in CD8 T<sub>FR</sub>, T<sub>FH</sub>, and B cell co-cultures as measured by ELISA. All co-cultures are 1:1 (n = 7). Statistical significance was determined by non-parametric Wilcoxon matched-pairs tests (B) or one-way ANOVA (Friedman test, C) and is displayed as * = p&lt;0.05, ** = p&lt;0.01 and *** = p&lt;0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.g003" xlink:type="simple"/>
</fig>
<p>Next, we determined if CD8 T<sub>FR</sub> influence total IgG production in tonsil cultures. We cultured isolated GC B cells (CD19+CD38+) with CD8 conv, CD8 T<sub>FR</sub>, and/or T<sub>FH</sub> at equal ratios, mock- or X4-spinoculated the cells, and stimulated them with CpG-B for 6 days. There is not increased IgG production in T<sub>FH</sub> and B cell co-cultures compared to B cells alone, likely due to the use of CpG-B that activates B cells directly through TLR9. In X4-spinoculated experiments, adding CD8 T<sub>FR</sub> to B cells alone or to B cells and T<sub>FH</sub> leads to decreased IgG production, however, adding CD8 conv to B cells has no effect on IgG production (<xref ref-type="fig" rid="ppat.1005924.g003">Fig 3D</xref>).</p>
</sec>
<sec id="sec006">
<title>CD8 T<sub>FR</sub> modestly reduce T<sub>FH</sub> permissivity to HIV</title>
<p>As HIV replication is highly concentrated within T<sub>FH</sub> <italic>ex vivo</italic> [<xref ref-type="bibr" rid="ppat.1005924.ref006">6</xref>] and <italic>in vivo</italic> [<xref ref-type="bibr" rid="ppat.1005924.ref001">1</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref004">4</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref005">5</xref>], we next investigated the effect of CD8 T<sub>FR</sub> on HIV replication in <italic>ex vivo</italic> infected tonsillar T<sub>FH</sub> using GFP-reporter viruses. Both the percentage of GFP+ T<sub>FH</sub> and the MFI of GFP is modestly reduced when sorted T<sub>FH</sub> are co-cultured 1:1 with CD8 T<sub>FR</sub> (<xref ref-type="fig" rid="ppat.1005924.g004">Fig 4A</xref>) following either X4- or R5-spinoculation. Co-culture with CD8 conv, on the other hand, does not alter HIV replication in T<sub>FH</sub> (<xref ref-type="supplementary-material" rid="ppat.1005924.s006">S6 Fig</xref>).</p>
<fig id="ppat.1005924.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005924.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Human tonsil CD8 T<sub>FR</sub> downregulate productive infection in T<sub>FH</sub> in a contact-dependent manner.</title>
<p>Tonsil cells were spinoculated with X4- or R5-tropic GFP-reporter HIV. T<sub>FH</sub> were cultured alone or at a 1:1 ratio with CD8 T<sub>FR</sub> for 2 days and analyzed by flow cytometry (n = 10). (A) Percent GFP+ T<sub>FH</sub> and T<sub>FH</sub> GFP MFI. (B) The percent R5-GFP+ T<sub>FH</sub> when co-cultured with CD8 T<sub>FR</sub> and either isotype control antibody or HLA-E blocking antibody (500 ng/μl, n = 2). (C) The percent R5-GFP+ T<sub>FH</sub> when co-cultured with CD8 T<sub>FR</sub> and either isotype control antibody or IL-10 blocking antibody (ng/μl, n = 2). (D) The percent R5-GFP+ T<sub>FH</sub> when co-cultured in contact with or not in contact with CD8 T<sub>FR</sub> and conventional CD8 (n = 4). Statistical significance was determined by Wilcoxon matched-pairs tests and is displayed as * = p&lt;0.05 and ** = p&lt;0.01.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.g004" xlink:type="simple"/>
</fig>
<p>We next investigated potential mechanisms by which CD8 T<sub>FR</sub> reduce HIV replication in T<sub>FH</sub>. In mice, CD8 T<sub>FR</sub> inhibit T<sub>FH</sub> responses via Qa-1 [<xref ref-type="bibr" rid="ppat.1005924.ref019">19</xref>], the mouse equivalent of the HLA-E molecule. To determine whether this mechanism restricts viral replication in T<sub>FH</sub>, we added HLA-E blocking antibodies to co-cultures. Blocking HLA-E interactions in 1:1 CD8 T<sub>FR</sub> and T<sub>FH</sub> co-cultures has no effect on viral replication (<xref ref-type="fig" rid="ppat.1005924.g004">Fig 4B</xref>). HIV replication has also been shown to be inhibited by IL-10 in PHA-blasted PBMCs and cell lines [<xref ref-type="bibr" rid="ppat.1005924.ref037">37</xref>]. Nevertheless, we do not observe differences in viral replication in co-cultures of CD8 T<sub>FR</sub> and T<sub>FH</sub> with addition of IL-10 neutralizing antibodies (<xref ref-type="fig" rid="ppat.1005924.g004">Fig 4C</xref>). However, inhibition of HIV replication in T<sub>FH</sub> by CD8 T<sub>FR</sub> is contact-dependent, as inhibition is not observed when cells are separated by transwell membranes in 4 separate experiments (<xref ref-type="fig" rid="ppat.1005924.g004">Fig 4D</xref>).</p>
</sec>
<sec id="sec007">
<title>CD8 T<sub>FR</sub> induce apoptosis in T<sub>FH</sub> via HLA-E</title>
<p>As CD8 T<sub>FR</sub> are located within the follicle, their ability (or lack thereof) to kill T<sub>FH</sub> is important for understanding their role in the follicular concentration of HIV replication. In mice, CD8 T<sub>FR</sub> are able to recognize and kill autoreactive T<sub>FH</sub> via Qa-1 interaction [<xref ref-type="bibr" rid="ppat.1005924.ref019">19</xref>]. Therefore, we wanted to determine if HLA-E, the human equivalent of Qa-1, similarly allowed CD8 T<sub>FR</sub> to kill T<sub>FH</sub> in tonsil cultures. As tonsil cells are from HIV-uninfected subjects, we did not expect to see virus-specific killing and looked broadly at T<sub>FH</sub> apoptosis rates using Annexin-V. We investigated the rate of apoptosis in mock-, X4-, and R5-spinoculated T<sub>FH</sub> alone or in co-culture with CD8 T<sub>FR</sub> or CD8 conv. After cell populations were sorted, all cells were spinoculated, cultured together at 1:1 ratios for 2 days, and stained for Annexin-V to determine apoptosis rates of T<sub>FH</sub>. When cultured at a ratio of 1:1 with T<sub>FH</sub>, CD8 T<sub>FR</sub> induce less apoptosis in T<sub>FH</sub> than CD8 conv (representative examples: <xref ref-type="fig" rid="ppat.1005924.g005">Fig 5A</xref>, cumulative data and 5B). We find that the rate of apoptosis in T<sub>FH</sub> is reduced further by blocking HLA-E in 1:1 CD8 T<sub>FR</sub> and T<sub>FH</sub> co-cultures (<xref ref-type="fig" rid="ppat.1005924.g005">Fig 5A and 5B</xref>). Blocking HLA-E in CD8 conv/T<sub>FH</sub> co-cultures has no effect (<xref ref-type="fig" rid="ppat.1005924.g005">Fig 5A and 5B</xref>). The use of count beads during co-culture analyses shows that conventional CD8 T cells reduce the number of T<sub>FH</sub> in both X4- and R5-spinoculation, while co-culturing T<sub>FH</sub> with CD8 T<sub>FR</sub> reduces T<sub>FH</sub> numbers to a lesser extent (<xref ref-type="fig" rid="ppat.1005924.g005">Fig 5C</xref>).</p>
<fig id="ppat.1005924.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005924.g005</object-id>
<label>Fig 5</label>
<caption>
<title>CD8 T<sub>FR</sub> induces T<sub>FH</sub> apoptosis via HLA-E.</title>
<p>Human tonsil cells were sorted to isolate CD8 T<sub>FR</sub>, CD8 conv, and T<sub>FH</sub>, spinoculated with R5-tropic HIV, and cultured for 2 days. (A) Representative flow plots showing the percent of Annexin-V+ T<sub>FH</sub> in co-culture at 1:1 ratio with CD8 T<sub>FR</sub> or CD8 conv 2 days after R5-spinoculatoin. (B) Results from a total of 6 tonsil for mock-, X4-, and R5-spinoculation (isotype n = 3) in A. Co-cultures were also performed with HLA-E blocking antibody or isotype controls (500 ng/μl). (C) Number of T<sub>FH</sub> per microliter on day 0 and day 2 when cultured alone (circle, triangle), 1:1 with CD8 T<sub>FR</sub> (square), or 1:1 with conventional CD8 T cells (upside down triangle) (n = 6). Statistical significance was determined by Wilcoxon matched-pairs tests and is displayed as * = p&lt;0.05 and ** = p&lt;0.01.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.g005" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec008">
<title>CD8 T<sub>FR</sub> increase and have a distinct phenotype during chronic SIV infection</title>
<p>Next, we investigated the effects of SIV infection on the frequency of CD8 T<sub>FR</sub> in secondary lymphoid tissues <italic>in vivo</italic>. Using the same phenotype as in 1A for human tonsils, we define CD8 T<sub>FR</sub> as viable CD3+CD8+CXCR5<sup>hi</sup>CD44<sup>hi</sup> cells (<xref ref-type="fig" rid="ppat.1005924.g006">Fig 6A</xref>). We compared the percentage of CD8 T<sub>FR</sub> in disaggregated spleen and lymph nodes from chronically SIV-infected rhesus macaques to those from SIV-uninfected controls and find that percentages of CD8 T<sub>FR</sub> are increased a median of 4-fold during SIV infection compared to uninfected controls (<xref ref-type="fig" rid="ppat.1005924.g006">Fig 6B</xref>). Additionally, we determined whether the proportion of SIV-specific cells differed among CD8 conv and CD8 T<sub>FR</sub>. We find that the frequency of SIV-Gag specific CD8 T<sub>FR</sub> is similar to that of CD8 conv (<xref ref-type="fig" rid="ppat.1005924.g006">Fig 6C</xref>). There were positive, but statistically insignificant correlations between the percent CD8 T<sub>FR</sub> or percent tetramer+ CD8 T<sub>FR</sub> and viral loads (<xref ref-type="supplementary-material" rid="ppat.1005924.s007">S7 Fig</xref>).</p>
<fig id="ppat.1005924.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005924.g006</object-id>
<label>Fig 6</label>
<caption>
<title>CD8 T<sub>FR</sub> are higher in SIV-infected than uninfected rhesus macaques.</title>
<p>Disaggregated cells from lymph nodes and spleen of SIV-uninfected (n = 6) and SIV-infected (n = 6) rhesus macaques were analyzed for CD8 T<sub>FR</sub> by flow cytometry. (A) Flow gating strategy to determine viable CD8 T<sub>FR</sub> (CD3+CD8+CXCR5<sup>hi</sup>CD44<sup>hi</sup>) and CD8 conv. (B) Percent CD8 T<sub>FR</sub> in SIV-uninfected compared to SIV-infected rhesus macaques. (C) Percent of SIV-Gag tetramer+ CD8 T<sub>FR</sub> compared to CD8 conv. CD8 T<sub>FR</sub> and CD8 conv from SIV-uninfected and SIV-infected rhesus macaques were analyzed for percent or MFI expression of (D) Tim-3, (E) perforin, (F) IL-10, and (G) GITR. Graphs depict median and range. Statistical significance was determined by non-parametric one-way ANOVA (Friedman test) and is displayed as * = p&lt;0.05 and *** = p&lt;0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.g006" xlink:type="simple"/>
</fig>
<p>We determined the expression of key CD8 regulatory molecules on CD8 T<sub>FR</sub> in rhesus macaques as done with human tonsils in <xref ref-type="fig" rid="ppat.1005924.g002">Fig 2</xref>. In chronically SIV-infected animals, there is a significantly greater frequency of Tim-3+ CD8 T<sub>FR</sub> compared to CD8 conv (<xref ref-type="fig" rid="ppat.1005924.g006">Fig 6D</xref>). Perforin expression on CD8 conv is significantly greater in SIV-infected compared to SIV-uninfected animals, while CD8 T<sub>FR</sub> do not display this trend and have significantly less perforin than CD8 T conv in SIV-infected animals (<xref ref-type="fig" rid="ppat.1005924.g006">Fig 6E</xref>). The percentage of CD8 T<sub>FR</sub> that produce IL-10 is higher than CD8 conv in both SIV-uninfected and chronically SIV-infected macaques. Furthermore, the percentage of CD8 T<sub>FR</sub> that produce IL-10 is higher in SIV-infected compared to uninfected animals (<xref ref-type="fig" rid="ppat.1005924.g006">Fig 6F</xref>). The percentage of IL-10 producing CD8 conv is similar in uninfected and SIV-infected macaques (<xref ref-type="fig" rid="ppat.1005924.g006">Fig 6F</xref>). The percentage of Galectin-9 (Gal-9)+ CD8 T<sub>FR</sub> tends to be higher than the percentage of Gal-9+ CD8 T conv in SIV-infected animals, but differences were not statistically significant (<xref ref-type="supplementary-material" rid="ppat.1005924.s008">S8 Fig</xref>), while GITR is significantly increased on CD8 T<sub>FR</sub> in both SIV-uninfected and SIV-infected animals (<xref ref-type="fig" rid="ppat.1005924.g006">Fig 6G</xref>).</p>
</sec>
<sec id="sec009">
<title>The majority of follicular CD8 T cells in chronic SIV infection are CD8 T<sub>FR</sub></title>
<p>As shown previously for human tonsils in <xref ref-type="fig" rid="ppat.1005924.g002">Fig 2</xref>, we determined the phenotype of CD8 T cells expressing the follicular homing profile CXCR5+CCR7- in lymph node and spleen of uninfected or chronically SIV-infected rhesus macaques. The vast majority of CXCR5+CCR7- cells are CD8 T<sub>FR</sub> (median 89% of uninfected, 93% of SIV-infected) whereas only a minority of CD8 conv exhibit a follicular homing phenotype (<xref ref-type="fig" rid="ppat.1005924.g007">Fig 7A</xref>). We further analyzed CCR7 expression on both CD8 T<sub>FR</sub> and CD8 conv. The percent of CCR7 positive cells is significantly higher in CD8 conv than CD8 T<sub>FR</sub> in both SIV-infected and uninfected rhesus macaques (<xref ref-type="fig" rid="ppat.1005924.g007">Fig 7B</xref>). Further, we performed immunofluorescent staining of lymph node and spleen tissue sections to determine the precise location of CXCR5+ CD8 T cells. As shown in representative images (<xref ref-type="fig" rid="ppat.1005924.g007">Fig 7C</xref>), the follicle was defined as CD20+ (white) and the number of CD8 T cells (green) expressing CXCR5 (red) were counted as either inside the follicle or in the extrafollicular zone. Most CXCR5+ CD8 T cells, a median of 91% in chronically infected rhesus macaques and a median of 93% in uninfected rhesus macaques, were found inside of the follicle (<xref ref-type="fig" rid="ppat.1005924.g007">Fig 7D</xref>). In light of findings above indicating that the vast majority of CXCR5+CD8+ T cells exhibit a CD8 T<sub>FR</sub> phenotype, it is reasonable to conclude that most cells with that phenotype reside in the follicle.</p>
<fig id="ppat.1005924.g007" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005924.g007</object-id>
<label>Fig 7</label>
<caption>
<title>Most rhesus macaque CXCR5+CCR7- CD8 T cells are CD8 T<sub>FR</sub>.</title>
<p>Disaggregated cells from lymph node and spleen of SIV-uninfected (n = 6) and SIV-infected (n = 6) rhesus macaques were analyzed by flow cytometry. (A) Percentages of CD8 T<sub>FR</sub> and CD8 conv from all CD3+CD8+CXCR5+CCR7- are shown for SIV-uninfected and SIV-infected animals. (B) The percent CCR7+ cells in CD8 T<sub>FR</sub> and CD8 conv cell populations(C) Representative images of rhesus macaque spleen tissue staining. CD20 staining was performed to determine follicular (F) and extrafollicular (EF) regions. (D) The percentage of CXCR5+ CD8 T cells in follicular and extrafollicular regions as determined from images similar to C. Left plot (white bars) show uninfected rhesus macaques, right plot (black bars) show chronically infected rhesus macaques. LN = lymph node, Mes = mesenteric, Ing = inguinal, Ax = axial, and Sp = spleen. Graphs depict median and range. Statistical significance was determined by non-parametric one-way ANOVA (Friedman test) and is displayed as *** = p&lt;0.001.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.g007" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec010">
<title>CD8 T<sub>FR</sub> inhibit T<sub>FH</sub> function via Tim-3 and induce T<sub>FH</sub> apoptosis via HLA-E in chronic SIV infection</title>
<p>Utilizing isolated CD8 T<sub>FR</sub> and T<sub>FH</sub> from chronically SIV-infected rhesus macaques, we determined if CD8 T<sub>FR</sub> regulated T<sub>FH</sub> function or apoptosis rates. Using disaggregated lymph node cells from 2 SIV-infected animals, we find that IL-21 production by T<sub>FH</sub> is inhibited when cultured with equal numbers of CD8 T<sub>FR</sub> (<xref ref-type="fig" rid="ppat.1005924.g008">Fig 8A</xref>) but not CD8 conv (<xref ref-type="supplementary-material" rid="ppat.1005924.s009">S9A Fig</xref>). IL-21 production by T<sub>FH</sub> is not reduced in co-cultures treated with Tim-3 neutralizing antibodies in culture (<xref ref-type="fig" rid="ppat.1005924.g008">Fig 8A</xref>). The percentage of apoptotic T<sub>FH</sub>, determined by Annexin-V staining, is increased when T<sub>FH</sub> are cultured with equal numbers of CD8 T<sub>FR</sub> (<xref ref-type="fig" rid="ppat.1005924.g008">Fig 8B</xref>). When HLA-E interactions are blocked with neutralizing antibodies in T<sub>FH</sub>: CD8 T<sub>FR</sub> co-cultures, the percentage of Annexin-V+ T<sub>FH</sub> decreases (<xref ref-type="fig" rid="ppat.1005924.g008">Fig 8B</xref>) but not when cultured with CD8 conv (<xref ref-type="supplementary-material" rid="ppat.1005924.s009">S9B Fig</xref>).</p>
<fig id="ppat.1005924.g008" position="float">
<object-id pub-id-type="doi">10.1371/journal.ppat.1005924.g008</object-id>
<label>Fig 8</label>
<caption>
<title>CD8 T<sub>FR</sub> suppress IL-21 production in T<sub>FH</sub> via Tim-3 and induce apoptosis via HLA-E in SIV-infected rhesus macaques.</title>
<p>Disaggregated cells from lymphoid tissues of SIV-infected rhesus macaques (n = 2) were sorted for T<sub>FH</sub> and CD8 T<sub>FR</sub> and co-cultured at a 1:1 ratio for 2 days with or without HLA-E blocking antibody and analyzed by flow cytometry. (A) Flow gating showing the percent T<sub>FH</sub> producing IL-21, and (B) percent T<sub>FH</sub> expressing Annexin-V (n = 2).</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.g008" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec011" sec-type="conclusions">
<title>Discussion</title>
<p>This is the first study to examine the role of CD8 T<sub>FR</sub> in the context of HIV and SIV infection. We determined that the majority of follicular CD8 T cells in human tonsils, as well as in secondary lymphoid tissues from rhesus macaques, exhibit a CD8 T<sub>FR</sub> phenotype. Of all the CD8 T cells expressing the follicular homing profile CXCR5+CCR7-, 90% or more of these cells are CD8 T<sub>FR</sub> in both human tonsils and rhesus macaque lymphoid tissues. Furthermore, their percentage is higher in lymph nodes and spleens of chronically SIV-infected rhesus macaques compared to uninfected macaques. A greater percentage of CD8 T<sub>FR</sub> express IL-10 and CD8 T<sub>FR</sub> express relatively lower levels of perforin compared to CD8 conv. In <italic>ex vivo</italic> HIV spinoculation and chronic SIV infection, CD8 T<sub>FR</sub> inhibit IL-21 production by T<sub>FH</sub> and IL-21 production is rescued by Tim-3 blockade. Further, CD8 T<sub>FR</sub> inhibit IgG production by B cells in <italic>ex vivo</italic> HIV infection. Additionally, CD8 T<sub>FR</sub> significantly, albeit modestly, reduce T<sub>FH</sub> permissivity to HIV <italic>ex vivo</italic> through contact-dependent mechanisms. Compared to CD8 conv, CD8 T<sub>FR</sub> induce a low level of T<sub>FH</sub> apoptosis. Blocking HLA-E interaction in CD8 T<sub>FR</sub> and T<sub>FH</sub> co-cultures further reduces T<sub>FH</sub> apoptosis rates. Collectively, these studies demonstrate that CD8 T<sub>FR</sub> constitute the majority of CD8 cells in B cell follicles and contribute to impaired GC function in lentiviral infections.</p>
<p>Multiple factors may account for the inability of CD8 T cells to control HIV and SIV replication in the follicles. Heightened permissivity of T<sub>FH</sub> [<xref ref-type="bibr" rid="ppat.1005924.ref006">6</xref>] combined with a paucity of virus-specific CTL in B cell follicles may foster virus replication at those sites [<xref ref-type="bibr" rid="ppat.1005924.ref002">2</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref009">9</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref038">38</xref>]. Previous work in rhesus macaques has shown that CD8 is downregulated on SIV-specific cells entering the follicle [<xref ref-type="bibr" rid="ppat.1005924.ref039">39</xref>] and CD8 downregulation leads to impairments of CTL cytokine production and proliferation [<xref ref-type="bibr" rid="ppat.1005924.ref040">40</xref>]. It has been proposed that virus-specific CD8 T cells are exhausted in chronic infection [<xref ref-type="bibr" rid="ppat.1005924.ref041">41</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref042">42</xref>] or that virus escape mutations prevent virus-specific CD8 T cells from recognizing infected cells [<xref ref-type="bibr" rid="ppat.1005924.ref043">43</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref044">44</xref>], but these hypotheses do not fully account for the follicular concentration of HIV replication. Here, we show that most of the follicular CD8 T cells in humans and rhesus macaques are CD8 T<sub>FR</sub>, CD8 T<sub>FR</sub> induce T<sub>FH</sub> apoptosis at lower rates than CD8 conv, and blocking HLA-E recognition further reduces CD8 T<sub>FR</sub>–mediated apoptosis in T<sub>FH</sub>. We also demonstrate that CD8 T<sub>FR</sub> produce a modest, but statistically significant reduction in HIV replication in human tonsil cells infected <italic>ex vivo</italic>. In the LCMV-infected mouse model, Leong et. al. [<xref ref-type="bibr" rid="ppat.1005924.ref045">45</xref>] recently found that mice reconstituted with CXCR5+CD8 LCMV-specific T cells had 50% fewer LCMV-producing T<sub>FH</sub> compared to mice reconstituted with CXCR5-CD8 T cells. Additionally, this study showed that CXCR5+CD8 LCMV-specific T cells express less perforin and are less efficient killers of LCMV-infected cells than their CXCR5- counterparts <italic>ex vivo</italic> [<xref ref-type="bibr" rid="ppat.1005924.ref045">45</xref>]. These findings are consistent with our findings in the <italic>ex vivo</italic> HIV infection model and in chronic SIV infection that CD8 T<sub>FR</sub> express less perforin than conventional CD8 T cells in both human tonsils and rhesus macaque lymphoid tissues, and that they induce modest reductions in HIV replication and T<sub>FH</sub> apoptosis <italic>ex vivo</italic>. In marked contrast, He et. al. [<xref ref-type="bibr" rid="ppat.1005924.ref046">46</xref>], reported profound reductions between 100- and 1,000-fold in splenic viral loads in the presence of CXCR5+CD44<sup>hi</sup>CD8 T cells compared to CXCR5-CD44<sup>hi</sup>CD8 T cells using the LCMV-infected mouse model. Reasons for the discrepancy between this study and that of Leong et. al. are not clear, as similar markers were used to define follicular populations of CD8 T cells in their studies, and these were the same markers that we used to define T<sub>FR</sub> CD8 populations in our study. An important area of future investigation will be to determine if CD8 T<sub>FR</sub> killing capacity can be boosted numerically and functionally to reduce follicular HIV replication <italic>in vivo</italic>.</p>
<p>Mechanisms that underlie the modest reduction in HIV replication induced by CD8 T<sub>FR</sub> in our studies are not clear. This could be due to general immune suppressive mechanisms, such as lowering T<sub>FH</sub> activation levels, or alternatively through cell killing. Previous work has shown that CD4 Treg suppressed HIV replication in other CD4 T cell populations through contact-dependent inhibitory mechanisms rather than inducing cytotoxicity [<xref ref-type="bibr" rid="ppat.1005924.ref047">47</xref>]. CD4 and CD8 regulatory cell subsets likely have complex roles in HIV infection, as evidenced by their ability to inhibit effector functions, and also reduce HIV replication. Further, CD8 T<sub>FR</sub> may promote the follicular HIV reservoir by inhibiting T<sub>FH</sub> IL-21 production, as it has been shown that ART combined with IL-21 therapy results in lower viral loads and lower intestinal cell-associated SIV DNA in rhesus macaques when compared to ART alone [<xref ref-type="bibr" rid="ppat.1005924.ref048">48</xref>]. Determining at which point in the virus life cycle immune regulatory mechanisms inhibit viral replication could provide useful information to promote a balance of effector cell function and inhibition of HIV replication. As CD8 T<sub>FR</sub> display an ability to interfere with HIV replication <italic>ex vivo</italic>, future studies will be needed to determine if CD8 T<sub>FR</sub> inhibit viral replication or eliminate virus producing cells, as these both have distinct implications for HIV cure strategies.</p>
<p>In this study, we show that CD8 T<sub>FR</sub> expand in chronic SIV infection. However, we do not see this expansion in our <italic>ex vivo</italic> tonsil model after 2 days of infection. A likely explanation for this discrepancy is that the expansion of CD8 T<sub>FR</sub> is a result of antigen-specific expansion in chronic HIV or SIV infection, and therefore not recapitulated in an acute infection model. This is supported by our data that show CD8 T<sub>FR</sub> are SIV-specific at a similar frequency as CD8 conv. We have previously reported that total levels of CD8 expression in lymph node follicles increase in chronically HIV-infected subjects compared to seronegative individuals [<xref ref-type="bibr" rid="ppat.1005924.ref001">1</xref>]. The present study demonstrates that the increase of follicular CD8 T cells in chronic HIV infection is likely due to an expansion of CD8 T<sub>FR</sub>. Therapies aimed at generating protective virus-specific CTL in patients will need to verify that cytotoxic responses, as opposed to regulatory responses, are being produced in the follicle.</p>
<p>An interesting question remaining is how CD8 T<sub>FR</sub> are generated during HIV and SIV infection. It has been suggested that persistence of antigen is the cause of functional impairment of HIV-specific effector responses [<xref ref-type="bibr" rid="ppat.1005924.ref049">49</xref>]. T<sub>FH</sub> are expanded in HIV [<xref ref-type="bibr" rid="ppat.1005924.ref004">4</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref050">50</xref>] and SIV [<xref ref-type="bibr" rid="ppat.1005924.ref003">3</xref>] infection, upregulate HLA-E upon HIV infection [<xref ref-type="bibr" rid="ppat.1005924.ref051">51</xref>], and constant antigenic stimulation occurs in the follicle and GC [<xref ref-type="bibr" rid="ppat.1005924.ref052">52</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref053">53</xref>]. It is possible that CD8 T<sub>FR</sub> are generated through contact with HLA-E on T<sub>FH</sub> as they enter follicular and GC regions. These interactions could convert effective CTL into CD8 T<sub>FR</sub> and allow for HIV persistence in the follicle. Further investigation as to whether CD8 T<sub>FR</sub> migrate into the follicle or are converted from precursors after migrating into the follicle will be an important aspect of potentially manipulating or preventing this response to promote cytotoxicity.</p>
<p>It was shown that CD8 T cells from IL-15 knock-out mice lose suppressive capabilities [<xref ref-type="bibr" rid="ppat.1005924.ref019">19</xref>]. Importantly, CD8 Treg from these mice were unable to suppress T<sub>FH</sub> number, GC expansion, and IgG production. Interestingly, expansion and cytotoxicity of CD8 T cells is impaired in IL-21 knockout mice, but the combination of IL-21 and IL-15 synergistically improves CD8 effector function [<xref ref-type="bibr" rid="ppat.1005924.ref054">54</xref>]. Additionally, IL-15 has been shown to have therapeutic potential as an adjuvant in HIV vaccines [<xref ref-type="bibr" rid="ppat.1005924.ref055">55</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref056">56</xref>] and in restoring CTL function [<xref ref-type="bibr" rid="ppat.1005924.ref057">57</xref>, <xref ref-type="bibr" rid="ppat.1005924.ref058">58</xref>]. Here, we find that CD8 T<sub>FR</sub> have elevated IL-15R expression and suppress T<sub>FH</sub> IL-21 production in HIV infection <italic>ex vivo</italic>. As CD8 T<sub>FR</sub> have access to HIV-infected T<sub>FH</sub> in the GC, it will be interesting to determine if the use of IL-15 and IL-21 in HIV therapy increases CD8 T<sub>FR</sub> cytotoxic function and promotes the elimination of HIV-infected T<sub>FH</sub>.</p>
<p>In chronic HIV infection expression of exhaustion markers such as PD-1 [<xref ref-type="bibr" rid="ppat.1005924.ref042">42</xref>] and Tim-3 [<xref ref-type="bibr" rid="ppat.1005924.ref029">29</xref>] correlate with diminished cytotoxic capacity. The inhibitory cytokine IL-10 was specifically produced by Tim-3+PD-1+ CD8 T cells after stimulation with LCMV peptides, suggesting Tim-3 is a potential target to limit regulatory cytokine production and promote CTL function. We find that inhibition of Tim-3 prevents impairment of T<sub>FH</sub> function by CD8 T<sub>FR</sub>. Thus, Tim-3 blockade could provide a new mechanism to reverse CD8 regulatory functions and perhaps boost T<sub>FH</sub> function. Further studies addressing the inhibitory mechanisms of CD8 T<sub>FR</sub> and their role in T<sub>FH</sub> impairment would be useful to determine how to boost the high quality response of T<sub>FH</sub> to HIV vaccines.</p>
<p>Previous work in mice showed that CD8 T<sub>FR</sub> do not directly suppress antigen-specific antibody production [<xref ref-type="bibr" rid="ppat.1005924.ref019">19</xref>], however CD8 T cells have been shown to directly suppress non-specific antibody responses in other models [<xref ref-type="bibr" rid="ppat.1005924.ref059">59</xref>]. A previous study found that both CXCR5-CD8+ and CXCR5+CD8+ human tonsil cells supported IgG production by CD19+ B cells in uninfected, unstimulated conditions [<xref ref-type="bibr" rid="ppat.1005924.ref035">35</xref>]. Here we find that CD8 T<sub>FR</sub> are able to directly suppress total IgG production by B cells in a stimulated, HIV-spinoculated culture. This is not observed when B cells are cultured with CD8 conv, indicating a unique effect of CD8 T<sub>FR</sub> on GC B cells. A previous study using human tonsil cells showed that CD4 Treg were also able to suppress IgG production by B cells [<xref ref-type="bibr" rid="ppat.1005924.ref060">60</xref>]. Thus, the mechanism for direct suppression of B cells could be a general feature of all regulatory T cell subsets, through common expression of Tim-3 or GITR, or a mechanism unique to CD8 T<sub>FR</sub> such as sequestration of IL-15 since IL-15 knock-out mice have been shown to produce less IgG [<xref ref-type="bibr" rid="ppat.1005924.ref061">61</xref>]. Further, it is unknown at this time if CD8 T<sub>FR</sub> can suppress antibody production elicited by T<sub>FH</sub>, but it is likely as CD8 T<sub>FR</sub> strongly inhibited IL-21 production by T<sub>FH</sub>. Future studies to determine whether CD8 T<sub>FR</sub> suppress HIV-specific antibody responses are warranted. CD8 T<sub>FR</sub> suppression of B cell function could potentially account for why HIV-infected individuals have poor responses to T cell-independent vaccines, such as the polysaccharide vaccines against <italic>pneumococcus</italic> [<xref ref-type="bibr" rid="ppat.1005924.ref062">62</xref>] and <italic>S</italic>. <italic>typhi</italic> [<xref ref-type="bibr" rid="ppat.1005924.ref063">63</xref>]. A better understanding of the role of CD8 T<sub>FR</sub> in generation of antigen-specific antibody responses could lead to innovative strategies to improve vaccine responses in HIV-infected individuals.</p>
<p>Reduction of pro-inflammatory responses prior to high-dose SIV challenge prevented mucosal transmission [<xref ref-type="bibr" rid="ppat.1005924.ref064">64</xref>], suggesting regulatory immune cell function could be an important aspect of reducing HIV infection and replication. Interestingly, the induction of immune tolerance via CD8 Tregs was shown to have a protective role in rhesus macaques prior to SIV challenge [<xref ref-type="bibr" rid="ppat.1005924.ref065">65</xref>]. Specifically, non-classical MHC-Ib/E restricted CD8 T cells from SIV-immunized animals inhibited CD4 T cell activation and SIV replication within autologous CD4 T cells infected <italic>ex vivo</italic>, but only if the CD8 T cells were added within 48 hours [<xref ref-type="bibr" rid="ppat.1005924.ref065">65</xref>]. We similarly observe that CD8 T<sub>FR</sub> reduce HIV replication in T<sub>FH</sub> <italic>ex vivo</italic> after 2 days. Taken together with our results that CD8 T<sub>FR</sub> induce less apoptosis in T<sub>FH</sub> than conventional CD8 T cells, we hypothesize that CD8 T<sub>FR</sub> would limit cellular activation and HIV replication within T<sub>FH</sub> on a per cell basis whereas CTL would reduce the number of HIV-infected T<sub>FH</sub>. However, these data were obtained in an <italic>ex vivo</italic> infection model and lack HIV-specific responses, so further studies <italic>in vivo</italic> would be necessary to determine if CD8 T<sub>FR</sub> and CTL differentially affect the follicular HIV reservoir. Although we observe only modest reductions in HIV replication in tonsil cells infected <italic>ex vivo</italic>, our data supports the notion that inflammation and cellular activation promote HIV infection and replication. However, regulation of infected cells may have drawbacks, as opposed to benefits prior to infection. An in-depth analysis is necessary to determine if immune regulatory activity on infected cells is inhibiting replication pre- or post-integration and if this promotes formation of the latent HIV reservoir.</p>
<p>In this study, we find that most follicular CD8 T cells are CD8 T<sub>FR</sub> and they potently impair T<sub>FH</sub> and GC B cell responses. The heightened regulatory function and relative lack of cytolytic potential of CD8 T<sub>FR</sub> could contribute to viral persistence in the follicle and impairments of humoral immunity that are characteristic of HIV and SIV infection. This is a novel mechanism of regulation of humoral immunity and remains to be explored in the context of other human diseases. Development of therapies that block CD8 T<sub>FR</sub> interaction with T<sub>FH</sub> and GC B cells could lead to novel approaches to improve the quality of antibody responses in HIV infection.</p>
</sec>
<sec id="sec012" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec013">
<title>Ethics statement</title>
<p>Human tonsils were obtained from the Colorado Children’s Hospital (Aurora, Colorado, USA) following routine tonsillectomy from individuals at low risk for HIV infection. Use of tonsil specimens for these studies was reviewed by the Colorado Multiple Institutional Review Board and determined to not constitute human subjects research (COMIRB approval no. APP001-1), in accordance with guidelines issued by the Office of Human Research Protections (<ext-link ext-link-type="uri" xlink:href="http://www.hhs.gov/ohrp/policy/checklists/decisioncharts.html" xlink:type="simple">http://www.hhs.gov/ohrp/policy/checklists/decisioncharts.html</ext-link>), and consequently, informed consent was not required. All research involving human subjects conformed to the principles set forth in the Declaration of Helsinki and was approved by the Colorado Multiple Institutional Review Board. Rhesus macaques were cared for according to the guidelines of the Animal Welfare Act and the NIH for housing and care of laboratory animals. Animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Wisconsin (IACUC; protocol G00632). Procedures were performed to ensure that discomfort was limited to that unavoidable in the conduct of the research plan. Animals were housed at the Wisconsin National Primate Research Center (WNPRC), which is accredited by American Association of Accreditation of Laboratory Animal Care (Animal Welfare Assurance No. A3368-01). Sedatives were applied as necessary for blood and tissue collections and analgesics were used when determined appropriate by veterinary medical staff. Animals were fed standard monkey chow twice daily. Pain, distress, animal behavior, food and drink consumption was monitored and adjustments were made as necessary. SIV-infected rhesus macaques were singly housed, but had visual and auditory contact with at least one social partner, permitting the expression of non-contact social behavior. Animals had access to more than one category of enrichment at WNPRC. The IACUC proposal included a written scientific justification for any exclusion from some parts of the enrichment plan. Research-related exemptions are reviewed at least annually.</p>
</sec>
<sec id="sec014">
<title>Macaques</title>
<p>Lymph nodes and spleen were obtained from 6 SIVmac239-infected and 6 uninfected Indian rhesus macaques (<italic>Macaca mulatta</italic>). Animals were infected either intravenously or intrarectally with SIVmac239, and had been infected from 12 to 241 weeks (median, 19.5 weeks) at the time that specimens were obtained. Plasma SIV RNA concentrations ranged from 3.78 to 6.45 log<sub>10</sub> copies/ml (median, 5.45 log<sub>10</sub> copies/ml), and CD4+ T cell counts ranged from 291 to 422 cells/mm<sup>3</sup> (median, 362 cells/mm<sup>3</sup>). Of SIV-infected animals, 2 were female and ranged in age from 7 to 8 years old. Of SIV uninfected animals, 2 were female and ranged in age from 10 to 23 years old. Tissues were either shipped overnight on ice in cold RPMI 1640 and disaggregated, or disaggregated and cryopreserved at the Wisconsin National Primate Research Center and later shipped on liquid nitrogen to the University of Colorado.</p>
</sec>
<sec id="sec015">
<title>HIV reporter viruses and tonsil cultures</title>
<p>The HIV-1 NL4-3-based CXCR4 (X4)-tropic green fluorescent protein (GFP) reporter virus NLENG1-IRES [<xref ref-type="bibr" rid="ppat.1005924.ref066">66</xref>] and the CCR5 (R5)-tropic GFP reporter virus NLYUV3-GFP [<xref ref-type="bibr" rid="ppat.1005924.ref067">67</xref>] were used for tonsil cell infections. Virus stocks were prepared by transfecting 293T cells (ATCC) with either X4 or R5 plasmid constructs (Effectene, Qiagen 301425) in complete DMEM (DMEM + 10% FBS, pen/strep, and non-essential amino acids), collecting supernatants, and spinning at 800 <italic>x g</italic> to remove debris. Viral stocks were stored at -80°C prior to use. After disaggregation, 5 x 10<sup>6</sup> tonsil cells were spinoculated with either GFP reporter virus or a mock spinoculation with an equal volume of complete DMEM for 2 hours at 1200 <italic>x g</italic> at room temperature. Cells were washed to remove unbound virus and media, and cultured for 2 days at 37°C with 5% CO<sub>2</sub> in RPMI with 10% FBS, L-glutamine, and pen/strep (R10) at a density of 1.5 x 10<sup>6</sup> cells/mL. Cells were collected and immediately processed for analysis by flow cytometry.</p>
</sec>
<sec id="sec016">
<title>Flow cytometry and antibodies</title>
<p>Cells were blocked for 20 minutes with 2% BSA in PBS at 4°C and then stained for 30 minutes at 4°C in the dark. The following anti-human conjugated antibodies were used: CD3-APCCy7-UCHT1 (Tonbo 25–0038), CD8-eVolve605-RPA-T8 (eBioscience 83–0088), CD19-FITC-SJ25C1 (Tonbo 35–0198), CD38-violetFluor450-HIT2 (Tonbo 75–0389), CXCR5-PE-MU5UBEE (eBioscience 18–9185), PD-1-APC EH12.2H7 (BioLegend 329908), GITR-PECy7-eBioAITR (eBioscience 12–5875), CD44-APC-IM7 (Tonbo 20–0441), Tim3-APC-344823 (R&amp;D FAB2365A), IL-15R-FITC-eBioJM7A4 (eBioscience 11–7159), CD122-V421-Mikβ3 (BD 562887), PD-1-APC-EH12.2H7 (BioLegend 329908), CTLA-4-PECy5-BNI3 (BD 561717), CD62L-PE-SK11 (BD 341012), and CCR7-PECy7-3D12 (BD 557648). The same antibody panel was used for rhesus macaque cell staining with the exception of CD3 SP34-2 (BD 557757). All analyses were performed on Ghost Dye 510 (Tonbo 13–0870) negative cells. Cells were fixed with 2% paraformaldehyde. Fresh human tonsil cells were typically 70–90% viable after culture and cryopreserved rhesus macaque cells ranged from 40–80% viability after freeze/thaw. All antibodies were used at one test per 10<sup>6</sup> cells. Data were acquired on a custom LSR II flow cytometer (Serial # H47100196, BD Immunocytometry System, San Jose, CA) with BDFACS Diva (v6.1) and with a configuration of 6 filters (755LP, 685LP, 670LP, 635LP, 600LP, 550LP, and 505LP) on a blue laser (488 nm), 6 filters (750LP, 690LP, 635LP, 595LP, 505LP, and 450/50) on a violet laser (405 nm), and 3 filters (755LP, 685LP, and 670/30) on a red laser (633 nm). FCS files were analyzed using FlowJo (v10.7, Tree Star, Ashland, OR).</p>
</sec>
<sec id="sec017">
<title>Rhesus macaque tetramer staining</title>
<p>Briefly, biotinylated MHC class I monomers were loaded with peptides (NIH Tetramer Core Facility) and converted to MHC tetramers with APC streptavidin (Prozyme PJ27S). The MHC class I monomer Mamu-A*001:01 molecule loaded with SIV Gag CM9 (CTPYDINQM) peptides was used. Cryopreserved disaggregated lymphoid tissue cells were thawed, and 1–2 x 10<sup>6</sup> disaggregated cells were resuspended in 100 μL of tetramer staining buffer (5% fetal bovine serum in PBS with 0.06% sodium azide) and incubated with APC-labelled Gag CM9 tetramer concurrently with CXCR5-PE-MU5UBEE, CD8-eFlour605-RPA-T8, CD44-eFluor450-IM7, CD3-APC Cy7-SP34-2 and Ghost Violet 450 viability in the dark for 40 minutes at room temperature.</p>
</sec>
<sec id="sec018">
<title>Lymphoid tissue staining</title>
<p>SIV-uninfected (R05021 mesenteric lymph node, RhA578 inguinal lymph node, R05018 axial lymph node, and R05091 spleen) and chronically SIV-infected (R03111 spleen, Rh2123 spleen, R02017 inguinal lymph node, Rh2284 spleen, Rhax18 spleen, R02116 inguinal lymph node, and Ro1038 inguinal lymph node) rhesus macaque lymphoid tissues were analyzed as follows. Four micron frozen tissue samples were fixed in 1% paraformaldehyde and stained with Rabbit anti CD20 (Abcam, Cambridge, MA), Rat anti CD8 (Bio Rad, Hercules, CA) and mouse anti CXCR5 (NIH NHP Reagent Resource) followed by detection with AF647 Donkey anti rabbit, AF594 Goat anti Mouse (highly cross absorbed) and AF488 Goat anti rat (highly cross absorbed) (Thermo Fisher Scientific, Waltham, MA). Sections were counterstained with DAPI and imaged on a Leica IMI6000 inverted fluorescent microscope. Ten 40X images were analyzed using Qwin (Leica Microsystems) by first defining the follicular region and counting CD8+CXCR5+ cells within each region and calculating the frequency of cells both in and out of the follicle. An adjacent section was stained for CD20 only and visualized using Vector HP Immpress and Vector Red (Vector Laboratories, Burlingame, CA) and the total follicular and extrafollicular area determined using Qwin. The percentage of CD8+CXCR5+ cells in the follicle was determined based on the frequency of cells within the follicular and extrafollicular regions and the total areas of each region.</p>
</sec>
<sec id="sec019">
<title>Sorting and co-culture experiments</title>
<p>Human tonsil and rhesus macaque lymph node cells were sorted using a MoFlo Astrios EQ. Cells were sorted into T<sub>FH</sub> (CD3+CD8-CXCR5+), conventional CD8 (CD3+CD8+CXCR5-), CD8 T<sub>FR</sub> (CD3+CD8+CXCR5<sup>hi</sup>CD44<sup>hi</sup>), and GC B cell (CD19+CD38+) populations. After sorting, all tonsil cell subsets were spinoculated with X4- or R5-HIV GFP reporter viruses and cultured in R10. All cell populations were spinoculated to mirror whole tonsil cell cultures and allow for all cell populations to be exposed to virus. For measurements of T<sub>FH</sub> cytokine production, T<sub>FH</sub> were seeded at 1 x 10<sup>5</sup> cells in a 24 well plate and CD8 T<sub>FR</sub> were added at ratios of 1:1, 1:10, and 1:50. After 2 days, T<sub>FH</sub> were stimulated to measure IL-2 and IL-21 by ICS. For blocking experiments, T<sub>FH</sub> and CD8 T<sub>FR</sub> or conventional CD8 were cultured at a 1:1 ratio in the presence of 500 ng/μL anti-Tim-3 (Biolegend 345003) antibodies or 500 ng/μL anti-HLA-E (Biolegend 342602) antibodies for 2 days. In transwell assays, 4 x 10<sup>4</sup> T<sub>FH</sub> were cultured in the bottom compartment and 4 x 10<sup>4</sup> CD8 T<sub>FR</sub> or conventional CD8 T cells were added to the upper compartment of 96-well permeable support plates (Corning CLS3386) and cultured for 2 days.</p>
</sec>
<sec id="sec020">
<title>ICS assays</title>
<p>After 2 days of culture, tonsil cells were stimulated with 50 ng/mL of phorbol 12-myristate 13-acetate (PMA, Sigma P8139) and 1 μg/mL of ionomycin (Sigma I3909) in the presence of protein transport inhibitor containing monensin (BD GolgiStop) for 5 hours. Cells were then harvested, blocked and stained for surface markers as above, and then fixed and permeabilized using BD CytoFix/Cytoperm kit (554714) according to manufacturers’ instructions. Cells were then stained at 4°C for 30 minutes and analyzed for IL-2-PE-MQ1-17H12 (BD 559334), IL-10-eFluor450-JES3-9D7 (eBioscience), IL-21-AF647-3A3-N2.1 (BD 560493), and perforin-FITC-Pf344 (Mabtech 3465–7). All cytokine analyses were normalized to a mock-spinoculated control that received monensin but was not stimulated.</p>
</sec>
<sec id="sec021">
<title>IgG ELISA</title>
<p>After sorting, 5 x 10<sup>4</sup> GC B cells and CD8 T<sub>FR</sub> T<sub>FH</sub> were cultured in the presence or absence of T<sub>FH</sub> at ratios of 1:1:1. Cells were co-cultured in R10 for 6 days in 96 well plates and treated with either 2.5 μg/mL of CpG-B or were unstimulated. Media was collected and spun at 5,000 <italic>x</italic> g to remove cellular debris and stored at -80°C. ELISAs were performed using the total IgG kit (Ready set go, eBioscience 88–50550) according to manufacturer’s instructions. Briefly, 96 well plates were coated overnight with anti-human IgG and culture supernatants were diluted at a 1:10 ratio for detection. Supernatants were incubated on pre-coated plates for 2 hours, washed, and incubated with HRP anti-IgG for 1 hour. After addition of HRP substrate, plates were analyzed on a plate reader at 450 nm and IgG calculated based on standards.</p>
</sec>
<sec id="sec022">
<title>Cell proliferation</title>
<p>T<sub>FH</sub> (CD3+CD8-CXCR5+CD25-) were sorted and stained with proliferation dye (Cell Proliferation Dye eFluor670, eBioscience 65–0840) at a concentration of 0.5 μM. In a 96-well plate, pre-coated with 5 μg/mL anti-CD3 (Tonbo 40–0037) in PBS at 37°C for 2 hours, 10<sup>4</sup> T<sub>FH</sub> per well were cultured for 4 days in 200 μL R10 containing 2 μg/mL anti-CD28 (Tonbo 40–0289) and 10 U/mL IL-2 with an equal number of sorted CD8 T<sub>FR</sub> (CD3+CD8+CXCR5<sup>hi</sup>CD44<sup>hi</sup>) or alone. At day 4, cells were stained with viability dye (Ghost Violet 450, Tonbo 13–0863) and analyzed by flow cytometry.</p>
</sec>
<sec id="sec023">
<title>Statistical analysis</title>
<p>Comparisons of uninfected and SIV-infected rhesus macaque spleen or lymph nodes were performed using non-parametric Mann Whitney tests. Comparisons of tonsil cultures were performed using unpaired Mann Whitney or Friedman non-parametric tests. In direct comparisons of paired data, a paired Wilcoxon ranked sums test was performed to compare the two group medians of interest. Significance is denoted in each figure by asterisks, as * = p &lt; 0.05, ** = p&lt; 0.01, and *** = p &lt; 0.001. All statistical tests were performed with GraphPad Prism 6.</p>
</sec>
</sec>
<sec id="sec024">
<title>Supporting Information</title>
<supplementary-material id="ppat.1005924.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Human tonsil CD8 T<sub>FR</sub> do not numerically increase after HIV infection.</title>
<p>Tonsil cells were mock-spinoculated or spinoculated with X4- or R5-tropic HIV (n = 3, average shown). Cell numbers were determined using flow cytometry counting beads. Conventional CD8 T cells (blue line) and CD8 T<sub>FR</sub> (red line) concentrations are shown for (A) mock-, (B) X4-, and (C) R5-spinoculated cells.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1005924.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>CD8 T<sub>FR</sub> frequency and phenotype are not altered by cell culture conditions.</title>
<p>Tonsil cells (n = 6) were stained immediately after isolation (Day 0) or mock-spinoculated and cultured for 2 days prior to flow staining (Day 2). Perforin and IL-10 expression levels were determined after 4 hours of PMA/ionomycin stimulation in the presence of GolgiPlug (brefeldin A). Statistical significance was determined by Wilcoxon matched-pairs tests.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1005924.s003" mimetype="application/jpeg" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>A majority of CD8 T<sub>FR</sub> are effector memory cells and are distinct from conventional CD8 T cells.</title>
<p>Tonsil cells (n = 6) were isolated and immediately stained to determine effector (CD3+CD8+CD62L-CCR7-) and central (CD3+CD8+CD62L+CCR7+) memory populations. (A) PD-1 and CTLA-4 expression on effector and memory populations of CD8 T<sub>FR</sub> and conventional CD8 T cells. (B) The frequency of effector and central memory cells in CD8 T<sub>FR</sub> and conventional CD8 T cell populations and their expression of IL-10, CD122, GITR, and perforin. Perforin and IL-10 expression levels were determined after 4 hours of PMA/ionomycin stimulation in the presence of GolgiPlug (brefeldin A). Statistical significance was determined by Wilcoxon matched-pairs tests is displayed as * = p&lt;0.05.</p>
<p>(JPG)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1005924.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.s004" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Human tonsil T<sub>FH</sub> cytokine production is inhibited by CD8 T<sub>FR</sub> but not CD8 conv.</title>
<p>Tonsil cells were sorted into T<sub>FH</sub>, CD8 T<sub>FR</sub>, and CD8 conv populations. All cell populations were spinoculated with X4- or R5-tropic HIV and T<sub>FH</sub> were cultured for 2 days alone or with CD8 T<sub>FR</sub> or conventional CD8 T cells. (A) IL-2 production by T<sub>FH</sub> co-cultured with increasing ratios of CD8 T<sub>FR</sub> (n = 4). (B) IL-21 production (left) and IL-2 production (right) by T<sub>FH</sub> co-cultured 1:1 with conventional CD8 T cells (n = 2). (C) Representative example of IL-21 production by T<sub>FH</sub> co-cultured with conventional CD8 T cells and anti-Tim3 antibody (n = 6).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1005924.s005" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.s005" xlink:type="simple">
<label>S5 Fig</label>
<caption>
<title>Proliferation of T<sub>FH</sub> co-cultured with CD8 T<sub>FR</sub>.</title>
<p>Tonsil cells were sorted into T<sub>FH</sub>, CD8 T<sub>FR</sub>, and CD8 conv populations. T<sub>FH</sub> were stained with proliferation dye and cultured for 2 days either alone without stimulation (T<sub>FH</sub>, NS) or in the presence of stimulation anti-CD3/CD28 + IL-2 alone or 1:1 ratios with CD8 T<sub>FR</sub> or CD8 conv (n = 5).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1005924.s006" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.s006" xlink:type="simple">
<label>S6 Fig</label>
<caption>
<title>Tonsil conventional CD8 T cells do not suppress productive infection of T<sub>FH</sub>.</title>
<p>Tonsil cells were sorted into T<sub>FH</sub>, CD8 T<sub>FR</sub>, and CD8 conv populations. Populations were spinoculated with X4- or R5-tropic GFP reporter HIV. T<sub>FH</sub> were cultured for 2 days alone or 1:1 with CD8 T<sub>FR</sub> or CD8 conv. Percent of GFP+ T<sub>FH</sub> when cultured alone or with CD8 conv (X4: n = 7; R5: n = 6).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1005924.s007" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.s007" xlink:type="simple">
<label>S7 Fig</label>
<caption>
<title>Correlations of rhesus macaque CD8 T<sub>FR</sub> frequency to viral load.</title>
<p>Correlation of CD8 T<sub>FR</sub> frequencies in chronically SIV-infected rhesus macaques to plasma viral loads (n = 6). Statistical significance was determined by Spearman correlation tests.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1005924.s008" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.s008" xlink:type="simple">
<label>S8 Fig</label>
<caption>
<title>Galectin-9 expression increases on CD8 T<sub>FR</sub> in SIV-infected rhesus macaques.</title>
<p>Disaggregated cells from lymph node and spleen of SIV-uninfected and SIV-infected rhesus macaques were analysed for galectin-9 expression on CD8 T<sub>FR</sub> and CD8 conv (n = 6). Graphs depict median and range. Statistical significance was determined by one-way ANOVA and is displayed as * = p&lt;0.05.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="ppat.1005924.s009" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.ppat.1005924.s009" xlink:type="simple">
<label>S9 Fig</label>
<caption>
<title>Conventional CD8 T cells from SIV-infected rhesus macaques do not suppress IL-21 via Tim-3 and do not induce apoptosis via HLA-E.</title>
<p>Disaggregated cells from lymph node and spleen of SIV-infected rhesus macaques (n = 2) were sorted for T<sub>FH</sub> and CD8 conv and co-cultured at a 1:1 ratio for 2 days with or without blocking antibody as noted and analysed by flow cytometry. (A) Representative flow plots showing percent T<sub>FH</sub> producing IL-21, and (B) percent T<sub>FH</sub> binding of Annexin-V.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors would like to thank Gemma Parra (Summer Institute on Ignorance, Translating Translation and Scientific Questioning in the Global K-12 Community) for assistance with data analysis, and David Watkins and Nancy Wilson for sharing reagents and animal specimens. We acknowledge the NIH Tetramer Core Facility for provision of biotinylated MHC monomers. The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID,NIH: Human rIL-2 from Dr. Maurice Gately, Hoffmann—La Roche Inc. [<xref ref-type="bibr" rid="ppat.1005924.ref068">68</xref>].</p>
</ack>
<ref-list>
<title>References</title>
<ref id="ppat.1005924.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Folkvord</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Armon</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Connick</surname> <given-names>E</given-names></name>. <article-title>Lymphoid follicles are sites of heightened human immunodeficiency virus type 1 (HIV-1) replication and reduced antiretroviral effector mechanisms</article-title>. <source>AIDS Research &amp; Human Retroviruses</source>. <year>2005</year>;<volume>21</volume>(<issue>5</issue>):<fpage>363</fpage>–<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/aid.2005.21.363" xlink:type="simple">10.1089/aid.2005.21.363</ext-link></comment> <object-id pub-id-type="pmid">15929698</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Connick</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Folkvord</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Lind</surname> <given-names>KT</given-names></name>, <name name-style="western"><surname>Rakasz</surname> <given-names>EG</given-names></name>, <name name-style="western"><surname>Miles</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>NA</given-names></name>, <etal>et al</etal>. <article-title>Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL</article-title>. <source>The Journal of Immunology</source>. <year>2014</year>;<volume>193</volume>(<issue>11</issue>):<fpage>5613</fpage>–<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1401161" xlink:type="simple">10.4049/jimmunol.1401161</ext-link></comment> <object-id pub-id-type="pmid">25362178</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Petrovas</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Yamamoto</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Gerner</surname> <given-names>MY</given-names></name>, <name name-style="western"><surname>Boswell</surname> <given-names>KL</given-names></name>, <name name-style="western"><surname>Wloka</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>EC</given-names></name>, <etal>et al</etal>. <article-title>CD4 T follicular helper cell dynamics during SIV infection</article-title>. <source>The Journal of clinical investigation</source>. <year>2012</year>;<volume>122</volume>(<issue>9</issue>):<fpage>3281</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI63039" xlink:type="simple">10.1172/JCI63039</ext-link></comment> <object-id pub-id-type="pmid">22922258</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perreau</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Savoye</surname> <given-names>A-L</given-names></name>, <name name-style="western"><surname>De Crignis</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Corpataux</surname> <given-names>J-M</given-names></name>, <name name-style="western"><surname>Cubas</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Haddad</surname> <given-names>EK</given-names></name>, <etal>et al</etal>. <article-title>Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production</article-title>. <source>The Journal of experimental medicine</source>. <year>2013</year>;<volume>210</volume>(<issue>1</issue>):<fpage>143</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.20121932" xlink:type="simple">10.1084/jem.20121932</ext-link></comment> <object-id pub-id-type="pmid">23254284</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tenner-Racz</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Stellbrink</surname> <given-names>H-J</given-names></name>, <name name-style="western"><surname>Van Lunzen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>J-P</given-names></name>, <name name-style="western"><surname>Raschdorff</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>The unenlarged lymph nodes of HIV-1–infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy</article-title>. <source>The Journal of experimental medicine</source>. <year>1998</year>;<volume>187</volume>(<issue>6</issue>):<fpage>949</fpage>–<lpage>59</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.187.6.949" xlink:type="simple">10.1084/jem.187.6.949</ext-link></comment> <object-id pub-id-type="pmid">9500797</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kohler</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Pham</surname> <given-names>MN</given-names></name>, <name name-style="western"><surname>Folkvord</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Arends</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Miles</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Germinal Center T Follicular Helper Cells Are Highly Permissive to HIV-1 and Alter Their Phenotype during Virus Replication</article-title>. <source>The Journal of Immunology</source>. <year>2016</year>;<volume>196</volume>(<issue>6</issue>):<fpage>2711</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1502174" xlink:type="simple">10.4049/jimmunol.1502174</ext-link></comment> <object-id pub-id-type="pmid">26873986</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miles</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Folkvord</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Kimball</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Chamanian</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Meditz</surname> <given-names>AL</given-names></name>, <etal>et al</etal>. <article-title>Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection</article-title>. <source>Nature communications</source>. <year>2015</year>;<volume>6</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms9608" xlink:type="simple">10.1038/ncomms9608</ext-link></comment> <object-id pub-id-type="pmid">26482032</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haas</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Levy</surname> <given-names>DN</given-names></name>, <name name-style="western"><surname>Folkvord</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Connick</surname> <given-names>E</given-names></name>. <article-title>Distinct Patterns of Bcl-2 Expression Occur in R5-and X4-Tropic HIV-1-Producing Lymphoid Tissue Cells Infected Ex Vivo</article-title>. <source>AIDS research and human retroviruses</source>. <year>2015</year>;<volume>31</volume>(<issue>3</issue>):<fpage>298</fpage>–<lpage>304</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1089/aid.2014.0155" xlink:type="simple">10.1089/aid.2014.0155</ext-link></comment> <object-id pub-id-type="pmid">25353356</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Connick</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Mattila</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Folkvord</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Schlichtemeier</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Meditz</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Ray</surname> <given-names>MG</given-names></name>, <etal>et al</etal>. <article-title>CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue</article-title>. <source>The Journal of Immunology</source>. <year>2007</year>;<volume>178</volume>(<issue>11</issue>):<fpage>6975</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.178.11.6975" xlink:type="simple">10.4049/jimmunol.178.11.6975</ext-link></comment> <object-id pub-id-type="pmid">17513747</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sakaguchi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Asano</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Itoh</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Toda</surname> <given-names>M</given-names></name>. <article-title>Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases</article-title>. <source>The Journal of Immunology</source>. <year>1995</year>;<volume>155</volume>(<issue>3</issue>):<fpage>1151</fpage>–<lpage>64</lpage>. <object-id pub-id-type="pmid">7636184</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Asano</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Toda</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname> <given-names>S</given-names></name>. <article-title>Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation</article-title>. <source>The Journal of experimental medicine</source>. <year>1996</year>;<volume>184</volume>(<issue>2</issue>):<fpage>387</fpage>–<lpage>96</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.184.2.387" xlink:type="simple">10.1084/jem.184.2.387</ext-link></comment> <object-id pub-id-type="pmid">8760792</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hori</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nomura</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sakaguchi</surname> <given-names>S</given-names></name>. <article-title>Control of regulatory T cell development by the transcription factor Foxp3</article-title>. <source>Science</source>. <year>2003</year>;<volume>299</volume>(<issue>5609</issue>):<fpage>1057</fpage>–<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1079490" xlink:type="simple">10.1126/science.1079490</ext-link></comment> <object-id pub-id-type="pmid">12522256</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mayer</surname> <given-names>CT</given-names></name>, <name name-style="western"><surname>Floess</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Baru</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Lahl</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Huehn</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sparwasser</surname> <given-names>T</given-names></name>. <article-title>CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity</article-title>. <source>European journal of immunology</source>. <year>2011</year>;<volume>41</volume>(<issue>3</issue>):<fpage>716</fpage>–<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/eji.201040913" xlink:type="simple">10.1002/eji.201040913</ext-link></comment> <object-id pub-id-type="pmid">21312192</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Joosten</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>van Meijgaarden</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Savage</surname> <given-names>ND</given-names></name>, <name name-style="western"><surname>de Boer</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Triebel</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>van der Wal</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2007</year>;<volume>104</volume>(<issue>19</issue>):<fpage>8029</fpage>–<lpage>34</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0702257104" xlink:type="simple">10.1073/pnas.0702257104</ext-link></comment> <object-id pub-id-type="pmid">17483450</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boer</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Joosten</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Ottenhoff</surname> <given-names>TH</given-names></name>. <article-title>Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination</article-title>. <source>Frontiers in Immunology</source>. <year>2015</year>;<volume>6</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fimmu.2015.00217" xlink:type="simple">10.3389/fimmu.2015.00217</ext-link></comment> <object-id pub-id-type="pmid">26029205</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Churlaud</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>pitoiset</surname> <given-names>f</given-names></name>, <name name-style="western"><surname>jebbawi</surname> <given-names>f</given-names></name>, <name name-style="western"><surname>lorenzon</surname> <given-names>r</given-names></name>, <name name-style="western"><surname>bellier</surname> <given-names>b</given-names></name>, <name name-style="western"><surname>rosenzwajg</surname> <given-names>m</given-names></name>, <etal>et al</etal>. <article-title>Human and mouse CD8+CD25+FOXP3+ regulatory T cells at steady state and during interleukin-2 therapy</article-title>. <source>Frontiers in Immunology</source>. <year>2015</year>;<volume>6</volume>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fimmu.2015.00171" xlink:type="simple">10.3389/fimmu.2015.00171</ext-link></comment> <object-id pub-id-type="pmid">25926835</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Noble</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>Z-S</given-names></name>, <name name-style="western"><surname>Cantor</surname> <given-names>H</given-names></name>. <article-title>Suppression of Immune Responses by CD8 Cells. II. Qa-1 on Activated B Cells Stimulates CD8 Cell Suppression of T Helper 2 Responses</article-title>. <source>The Journal of Immunology</source>. <year>1998</year>;<volume>160</volume>(<issue>2</issue>):<fpage>566</fpage>–<lpage>71</lpage>. <object-id pub-id-type="pmid">9551889</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Ikizawa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Sanchirico</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Shinohara</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Cantor</surname> <given-names>H</given-names></name>. <article-title>Analysis of regulatory CD8 T cells in Qa-1-deficient mice</article-title>. <source>Nature immunology</source>. <year>2004</year>;<volume>5</volume>(<issue>5</issue>):<fpage>516</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ni1063" xlink:type="simple">10.1038/ni1063</ext-link></comment> <object-id pub-id-type="pmid">15098030</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>H-J</given-names></name>, <name name-style="western"><surname>Verbinnen</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Lu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Cantor</surname> <given-names>H</given-names></name>. <article-title>Inhibition of follicular T-helper cells by CD8+ regulatory T cells is essential for self tolerance</article-title>. <source>Nature</source>. <year>2010</year>;<volume>467</volume>(<issue>7313</issue>):<fpage>328</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature09370" xlink:type="simple">10.1038/nature09370</ext-link></comment> <object-id pub-id-type="pmid">20844537</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jiang</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Chess</surname> <given-names>L</given-names></name>. <article-title>The Specific Regulation Of Immune Responses By CD8+ T Cells Restricted By The MHC Class Ib Molecule, Qa-1</article-title>. <source>Annual Review of Immunology</source>. <year>2000</year>;<volume>18</volume>(<issue>1</issue>):<fpage>185</fpage>–<lpage>216</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev.immunol.18.1.185" xlink:type="simple">10.1146/annurev.immunol.18.1.185</ext-link></comment> <object-id pub-id-type="pmid">10837057</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>H-J</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Radfar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sproule</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Roopenian</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Cantor</surname> <given-names>H</given-names></name>. <article-title>CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2011</year>;<volume>108</volume>(<issue>5</issue>):<fpage>2010</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1018974108" xlink:type="simple">10.1073/pnas.1018974108</ext-link></comment> <object-id pub-id-type="pmid">21233417</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Endharti</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Fukuoka</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Nakahara</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kawamoto</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Takeda</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Cutting edge: CD8+ CD122+ regulatory T cells produce IL-10 to suppress IFN-γ production and proliferation of CD8+ T cells</article-title>. <source>The Journal of Immunology</source>. <year>2005</year>;<volume>175</volume>(<issue>11</issue>):<fpage>7093</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.175.11.7093" xlink:type="simple">10.4049/jimmunol.175.11.7093</ext-link></comment> <object-id pub-id-type="pmid">16301610</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>H-J</given-names></name>, <name name-style="western"><surname>Lang</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Cantor</surname> <given-names>H</given-names></name>. <article-title>CD8+ Treg-From Mouse To Man</article-title>. <source>Blood</source>. <year>2013</year>;<volume>122</volume>(<issue>21</issue>):<fpage>3474</fpage>-.</mixed-citation></ref>
<ref id="ppat.1005924.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Garba</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Pilcher</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Bingham</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Eron</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Frelinger</surname> <given-names>JA</given-names></name>. <article-title>HIV antigens can induce TGF-β1-producing immunoregulatory CD8+ T cells</article-title>. <source>The Journal of Immunology</source>. <year>2002</year>;<volume>168</volume>(<issue>5</issue>):<fpage>2247</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.168.5.2247" xlink:type="simple">10.4049/jimmunol.168.5.2247</ext-link></comment> <object-id pub-id-type="pmid">11859112</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brockman</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Kwon</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Tighe</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Pavlik</surname> <given-names>DF</given-names></name>, <name name-style="western"><surname>Rosato</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Sela</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells</article-title>. <source>Blood</source>. <year>2009</year>;<volume>114</volume>(<issue>2</issue>):<fpage>346</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2008-12-191296" xlink:type="simple">10.1182/blood-2008-12-191296</ext-link></comment> <object-id pub-id-type="pmid">19365081</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Elrefaei</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ventura</surname> <given-names>FL</given-names></name>, <name name-style="western"><surname>Baker</surname> <given-names>CAR</given-names></name>, <name name-style="western"><surname>Clark</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bangsberg</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Cao</surname> <given-names>H</given-names></name>. <article-title>HIV-Specific IL-10-Positive CD8+ T Cells Suppress Cytolysis and IL-2 Production by CD8+ T Cells</article-title>. <source>The Journal of Immunology</source>. <year>2007</year>;<volume>178</volume>(<issue>5</issue>):<fpage>3265</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.178.5.3265" xlink:type="simple">10.4049/jimmunol.178.5.3265</ext-link></comment> <object-id pub-id-type="pmid">17312176</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Wan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zheng</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>ZK</given-names></name>. <article-title>Tim-3-Galectin-9 pathway involves the suppression induced by CD4+ CD25+ regulatory T cells</article-title>. <source>Immunobiology</source>. <year>2009</year>;<volume>214</volume>(<issue>5</issue>):<fpage>342</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.imbio.2008.10.007" xlink:type="simple">10.1016/j.imbio.2008.10.007</ext-link></comment> <object-id pub-id-type="pmid">19362679</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sehrawat</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Reddy</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Rajasagi</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Suryawanshi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hirashima</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rouse</surname> <given-names>BT</given-names></name>. <article-title>Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response</article-title>. <source>PLoS Pathog</source>. <year>2010</year>;<volume>6</volume>(<issue>5</issue>):<fpage>e1000882</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1000882" xlink:type="simple">10.1371/journal.ppat.1000882</ext-link></comment> <object-id pub-id-type="pmid">20463811</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jin</surname> <given-names>H-T</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>AC</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>WG</given-names></name>, <name name-style="western"><surname>West</surname> <given-names>EE</given-names></name>, <name name-style="western"><surname>Ha</surname> <given-names>S-J</given-names></name>, <name name-style="western"><surname>Araki</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2010</year>;<volume>107</volume>(<issue>33</issue>):<fpage>14733</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1009731107" xlink:type="simple">10.1073/pnas.1009731107</ext-link></comment> <object-id pub-id-type="pmid">20679213</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fourcade</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Benallaoua</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Guillaume</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Luescher</surname> <given-names>IF</given-names></name>, <name name-style="western"><surname>Sander</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients</article-title>. <source>The Journal of experimental medicine</source>. <year>2010</year>;<volume>207</volume>(<issue>10</issue>):<fpage>2175</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.20100637" xlink:type="simple">10.1084/jem.20100637</ext-link></comment> <object-id pub-id-type="pmid">20819923</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McMahan</surname> <given-names>RH</given-names></name>, <name name-style="western"><surname>Golden-Mason</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Nishimura</surname> <given-names>MI</given-names></name>, <name name-style="western"><surname>McMahon</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Kemper</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Allen</surname> <given-names>TM</given-names></name>, <etal>et al</etal>. <article-title>Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity</article-title>. <source>The Journal of clinical investigation</source>. <year>2010</year>;<volume>120</volume>(<issue>12</issue>):<fpage>4546</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI43127" xlink:type="simple">10.1172/JCI43127</ext-link></comment> <object-id pub-id-type="pmid">21084749</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jones</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Ndhlovu</surname> <given-names>LC</given-names></name>, <name name-style="western"><surname>Barbour</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Sheth</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Jha</surname> <given-names>AR</given-names></name>, <name name-style="western"><surname>Long</surname> <given-names>BR</given-names></name>, <etal>et al</etal>. <article-title>Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection</article-title>. <source>The Journal of experimental medicine</source>. <year>2008</year>;<volume>205</volume>(<issue>12</issue>):<fpage>2763</fpage>–<lpage>79</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.20081398" xlink:type="simple">10.1084/jem.20081398</ext-link></comment> <object-id pub-id-type="pmid">19001139</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nocentini</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Riccardi</surname> <given-names>C</given-names></name>. <article-title>GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily</article-title>. <source>European journal of immunology</source>. <year>2005</year>;<volume>35</volume>(<issue>4</issue>):<fpage>1016</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/eji.200425818" xlink:type="simple">10.1002/eji.200425818</ext-link></comment> <object-id pub-id-type="pmid">15770698</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Haynes</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Allen</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Lesley</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ansel</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Killeen</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Cyster</surname> <given-names>JG</given-names></name>. <article-title>Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation</article-title>. <source>The Journal of Immunology</source>. <year>2007</year>;<volume>179</volume>(<issue>8</issue>):<fpage>5099</fpage>–<lpage>108</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.179.8.5099" xlink:type="simple">10.4049/jimmunol.179.8.5099</ext-link></comment> <object-id pub-id-type="pmid">17911595</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Quigley</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Gonzalez</surname> <given-names>VD</given-names></name>, <name name-style="western"><surname>Granath</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Andersson</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sandberg</surname> <given-names>JK</given-names></name>. <article-title>CXCR5+ CCR7– CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles</article-title>. <source>European Journal of Immunology</source>. <year>2007</year>;<volume>37</volume>(<issue>12</issue>):<fpage>3352</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/eji.200636746" xlink:type="simple">10.1002/eji.200636746</ext-link></comment> <object-id pub-id-type="pmid">18000950</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Linterman</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Beaton</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Ramiscal</surname> <given-names>RR</given-names></name>, <name name-style="western"><surname>Srivastava</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hogan</surname> <given-names>JJ</given-names></name>, <etal>et al</etal>. <article-title>IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses</article-title>. <source>The Journal of experimental medicine</source>. <year>2010</year>;<volume>207</volume>(<issue>2</issue>):<fpage>353</fpage>–<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.20091738" xlink:type="simple">10.1084/jem.20091738</ext-link></comment> <object-id pub-id-type="pmid">20142429</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Masood</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Lunardiiskandar</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Moudgil</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Law</surname> <given-names>RE</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>IL-10 inhibits HIV-1 replication and is induced by tat</article-title>. <source>Biochemical and biophysical research communications</source>. <year>1994</year>;<volume>202</volume>(<issue>1</issue>):<fpage>374</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1006/bbrc.1994.1938" xlink:type="simple">10.1006/bbrc.1994.1938</ext-link></comment> <object-id pub-id-type="pmid">8037735</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fukazawa</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Lum</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Okoye</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Matsuda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Bae</surname> <given-names>JY</given-names></name>, <etal>et al</etal>. <article-title>B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers</article-title>. <source>Nature medicine</source>. <year>2015</year>;<volume>21</volume>(<issue>2</issue>):<fpage>132</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nm.3781" xlink:type="simple">10.1038/nm.3781</ext-link></comment> <object-id pub-id-type="pmid">25599132</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hong</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Reynolds</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Mattila</surname> <given-names>TL</given-names></name>, <name name-style="western"><surname>Hage</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Watkins</surname> <given-names>DI</given-names></name>, <name name-style="western"><surname>Miller</surname> <given-names>CJ</given-names></name>, <etal>et al</etal>. <article-title>Localized Populations of CD8 low/− MHC Class I Tetramer+ SIV-Specific T Cells in Lymphoid Follicles and Genital Epithelium</article-title>. <source>PLoS One</source>. <year>2009</year>;<volume>4</volume>(<issue>1</issue>):<fpage>e4131</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0004131" xlink:type="simple">10.1371/journal.pone.0004131</ext-link></comment> <object-id pub-id-type="pmid">19122815</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Lackner</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Veazey</surname> <given-names>RS</given-names></name>. <article-title>CD8 down-regulation and functional impairment of SIV-specific cytotoxic T lymphocytes in lymphoid and mucosal tissues during SIV infection</article-title>. <source>Journal of leukocyte biology</source>. <year>2013</year>;<volume>93</volume>(<issue>6</issue>):<fpage>943</fpage>–<lpage>50</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1189/jlb.1112580" xlink:type="simple">10.1189/jlb.1112580</ext-link></comment> <object-id pub-id-type="pmid">23519937</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Day</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Kaufmann</surname> <given-names>DE</given-names></name>, <name name-style="western"><surname>Kiepiela</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Moodley</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Reddy</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression</article-title>. <source>Nature</source>. <year>2006</year>;<volume>443</volume>(<issue>7109</issue>):<fpage>350</fpage>–<lpage>4</lpage>. <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/nature/journal/v443/n7109/suppinfo/nature05115_S1.html" xlink:type="simple">http://www.nature.com/nature/journal/v443/n7109/suppinfo/nature05115_S1.html</ext-link>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature05115" xlink:type="simple">10.1038/nature05115</ext-link></comment> <object-id pub-id-type="pmid">16921384</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Trautmann</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Janbazian</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chomont</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Said</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Gimmig</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bessette</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction</article-title>. <source>Nature medicine</source>. <year>2006</year>;<volume>12</volume>(<issue>10</issue>):<fpage>1198</fpage>–<lpage>202</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nm1482" xlink:type="simple">10.1038/nm1482</ext-link></comment> <object-id pub-id-type="pmid">16917489</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Borrow</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lewicki</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Horwitz</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Peffer</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Meyers</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus</article-title>. <source>Nature medicine</source>. <year>1997</year>;<volume>3</volume>(<issue>2</issue>):<fpage>205</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nm0297-205" xlink:type="simple">10.1038/nm0297-205</ext-link></comment> <object-id pub-id-type="pmid">9018240</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Price</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Goulder</surname> <given-names>PJR</given-names></name>, <name name-style="western"><surname>Klenerman</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Sewell</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Easterbrook</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Troop</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>1997</year>;<volume>94</volume>(<issue>5</issue>):<fpage>1890</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.94.5.1890" xlink:type="simple">10.1073/pnas.94.5.1890</ext-link></comment> <object-id pub-id-type="pmid">9050875</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leong</surname> <given-names>YA</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ong</surname> <given-names>HS</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Man</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Deleage</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>CXCR5+ follicular cytotoxic T cells control viral infection in B cell follicles</article-title>. <source>Nature immunology</source>. <year>2016</year>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ni.3543" xlink:type="simple">10.1038/ni.3543</ext-link></comment> <object-id pub-id-type="pmid">27487330</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hou</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bai</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection</article-title>. <source>Nature</source>. <year>2016</year>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature19317" xlink:type="simple">10.1038/nature19317</ext-link></comment> <object-id pub-id-type="pmid">27501245</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moreno-Fernandez</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Rueda</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Rusie</surname> <given-names>LK</given-names></name>, <name name-style="western"><surname>Chougnet</surname> <given-names>CA</given-names></name>. <article-title>Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism</article-title>. <source>Blood</source>. <year>2011</year>;<volume>117</volume>(<issue>20</issue>):<fpage>5372</fpage>–<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2010-12-323162" xlink:type="simple">10.1182/blood-2010-12-323162</ext-link></comment> <object-id pub-id-type="pmid">21436067</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Micci</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ryan</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Fromentin</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bosinger</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Harper</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>He</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques</article-title>. <source>The Journal of clinical investigation</source>. <year>2015</year>;<volume>125</volume>(<issue>12</issue>):<fpage>0</fpage>-. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI81400" xlink:type="simple">10.1172/JCI81400</ext-link></comment> <object-id pub-id-type="pmid">26551680</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Streeck</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Brumme</surname> <given-names>ZL</given-names></name>, <name name-style="western"><surname>Anastario</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cohen</surname> <given-names>KW</given-names></name>, <name name-style="western"><surname>Jolin</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Meier</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells</article-title>. <source>PLoS Med</source>. <year>2008</year>;<volume>5</volume>(<issue>5</issue>):<fpage>e100</fpage>–<lpage>e</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0050100" xlink:type="simple">10.1371/journal.pmed.0050100</ext-link></comment> <object-id pub-id-type="pmid">18462013</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lindqvist</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>van Lunzen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Soghoian</surname> <given-names>DZ</given-names></name>, <name name-style="western"><surname>Kuhl</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Ranasinghe</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kranias</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Expansion of HIV-specific T follicular helper cells in chronic HIV infection</article-title>. <source>The Journal of clinical investigation</source>. <year>2012</year>;<volume>122</volume>(<issue>9</issue>):<fpage>3271</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1172/JCI64314" xlink:type="simple">10.1172/JCI64314</ext-link></comment> <object-id pub-id-type="pmid">22922259</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nattermann</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nischalke</surname> <given-names>HD</given-names></name>, <name name-style="western"><surname>Hofmeister</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Kupfer</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Ahlenstiel</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Feldmann</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells</article-title>. <source>Antivir Ther</source>. <year>2005</year>;<volume>10</volume>(<issue>1</issue>):<fpage>95</fpage>–<lpage>107</lpage>. <object-id pub-id-type="pmid">15751767</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burton</surname> <given-names>GF</given-names></name>, <name name-style="western"><surname>Keele</surname> <given-names>BF</given-names></name>, <name name-style="western"><surname>Estes</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Thacker</surname> <given-names>TC</given-names></name>, <name name-style="western"><surname>Gartner</surname> <given-names>S</given-names></name>, editors. <article-title>Follicular dendritic cell contributions to HIV pathogenesis</article-title>. <source>Seminars in immunology</source>; <year>2002</year>: Elsevier. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1044-5323(02)00060-X" xlink:type="simple">10.1016/S1044-5323(02)00060-X</ext-link></comment> <object-id pub-id-type="pmid">12163303</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Popovic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tenner-Racz</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Pelser</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Stellbrink</surname> <given-names>H-J</given-names></name>, <name name-style="western"><surname>van Lunzen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Lewis</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2005</year>;<volume>102</volume>(<issue>41</issue>):<fpage>14807</fpage>–<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0506857102" xlink:type="simple">10.1073/pnas.0506857102</ext-link></comment> <object-id pub-id-type="pmid">16199516</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zeng</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Spolski</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Finkelstein</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Oh</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kovanen</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Hinrichs</surname> <given-names>CS</given-names></name>, <etal>et al</etal>. <article-title>Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function</article-title>. <source>The Journal of experimental medicine</source>. <year>2005</year>;<volume>201</volume>(<issue>1</issue>):<fpage>139</fpage>–<lpage>48</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.20041057" xlink:type="simple">10.1084/jem.20041057</ext-link></comment> <object-id pub-id-type="pmid">15630141</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oh</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Berzofsky</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Burke</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Waldmann</surname> <given-names>TA</given-names></name>, <name name-style="western"><surname>Perera</surname> <given-names>LP</given-names></name>. <article-title>Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2003</year>;<volume>100</volume>(<issue>6</issue>):<fpage>3392</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0630592100" xlink:type="simple">10.1073/pnas.0630592100</ext-link></comment> <object-id pub-id-type="pmid">12626740</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xin</surname> <given-names>K-Q</given-names></name>, <name name-style="western"><surname>Hamajima</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sasaki</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tsuji</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Watabe</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Okada</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine</article-title>. <source>Vaccine</source>. <year>1999</year>;<volume>17</volume>(<issue>7</issue>):<fpage>858</fpage>–<lpage>66</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0264-410X(98)00271-0" xlink:type="simple">10.1016/S0264-410X(98)00271-0</ext-link></comment> <object-id pub-id-type="pmid">10067692</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mueller</surname> <given-names>YM</given-names></name>, <name name-style="western"><surname>Bojczuk</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Halstead</surname> <given-names>ES</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>AH</given-names></name>, <name name-style="western"><surname>Witek</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>JD</given-names></name>, <etal>et al</etal>. <article-title>IL-15 enhances survival and function of HIV-specific CD8+ T cells</article-title>. <source>Blood</source>. <year>2003</year>;<volume>101</volume>(<issue>3</issue>):<fpage>1024</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2002-07-1957" xlink:type="simple">10.1182/blood-2002-07-1957</ext-link></comment> <object-id pub-id-type="pmid">12393488</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>White</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Krishnan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Strbo</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kolber</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Lichtenheld</surname> <given-names>MG</given-names></name>, <etal>et al</etal>. <article-title>Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV)</article-title>. <source>Blood</source>. <year>2007</year>;<volume>109</volume>(<issue>9</issue>):<fpage>3873</fpage>–<lpage>80</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2006-09-045278" xlink:type="simple">10.1182/blood-2006-09-045278</ext-link></comment> <object-id pub-id-type="pmid">17192392</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Renz</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Lack</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Saloga</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Schwinzer</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bradley</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Loader</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization</article-title>. <source>The Journal of Immunology</source>. <year>1994</year>;<volume>152</volume>(<issue>1</issue>):<fpage>351</fpage>–<lpage>60</lpage>. <object-id pub-id-type="pmid">8254203</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lim</surname> <given-names>HW</given-names></name>, <name name-style="western"><surname>Hillsamer</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Banham</surname> <given-names>AH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>CH</given-names></name>. <article-title>Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells</article-title>. <source>The Journal of Immunology</source>. <year>2005</year>;<volume>175</volume>(<issue>7</issue>):<fpage>4180</fpage>–<lpage>3</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.175.7.4180" xlink:type="simple">10.4049/jimmunol.175.7.4180</ext-link></comment> <object-id pub-id-type="pmid">16177055</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gill</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Paltser</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ashkar</surname> <given-names>AA</given-names></name>. <article-title>Interleukin-15 expression affects homeostasis and function of B cells through NK cell-derived interferon-γ</article-title>. <source>Cellular Immunology</source>. <year>2009</year>;<volume>258</volume>(<issue>1</issue>):<fpage>59</fpage>–<lpage>64</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cellimm.2009.03.010" xlink:type="simple">http://dx.doi.org/10.1016/j.cellimm.2009.03.010</ext-link>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cellimm.2009.03.010" xlink:type="simple">10.1016/j.cellimm.2009.03.010</ext-link></comment> <object-id pub-id-type="pmid">19361783</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>French</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Nakiyingi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Carpenter</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Lugada</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Watera</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Moi</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial</article-title>. <source>The Lancet</source>. <year>2000</year>;<volume>355</volume>(<issue>9221</issue>):<fpage>2106</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(00)02377-1" xlink:type="simple">10.1016/S0140-6736(00)02377-1</ext-link></comment> <object-id pub-id-type="pmid">10902624</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kroon</surname> <given-names>FP</given-names></name>, <name name-style="western"><surname>van Dissel</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Ravensbergen</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Nibbering</surname> <given-names>PH</given-names></name>, <name name-style="western"><surname>van Furth</surname> <given-names>R</given-names></name>. <article-title>Impaired antibody response after immunization of HIV-infected individuals with the polysaccharide vaccine against Salmonella typhi (Typhim-Vi<sup>®</sup>)</article-title>. <source>Vaccine</source>. <year>1999</year>;<volume>17</volume>(<issue>23</issue>):<fpage>2941</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0264-410X(99)00167-X" xlink:type="simple">10.1016/S0264-410X(99)00167-X</ext-link></comment> <object-id pub-id-type="pmid">10462227</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Estes</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Schlievert</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Duan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Brosnahan</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Southern</surname> <given-names>PJ</given-names></name>, <etal>et al</etal>. <article-title>Glycerol monolaurate prevents mucosal SIV transmission</article-title>. <source>Nature</source>. <year>2009</year>;<volume>458</volume>(<issue>7241</issue>):<fpage>1034</fpage>–<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/nature/journal/v458/n7241/suppinfo/nature07831_S1.html" xlink:type="simple">http://www.nature.com/nature/journal/v458/n7241/suppinfo/nature07831_S1.html</ext-link>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature07831" xlink:type="simple">10.1038/nature07831</ext-link></comment> <object-id pub-id-type="pmid">19262509</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Guo</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Fu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Andrieu</surname> <given-names>J-M</given-names></name>. <article-title>Induction of CD8+ regulatory T cells protects macaques against SIV challenge</article-title>. <source>Cell reports</source>. <year>2012</year>;<volume>2</volume>(<issue>6</issue>):<fpage>1736</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.celrep.2012.11.016" xlink:type="simple">10.1016/j.celrep.2012.11.016</ext-link></comment> <object-id pub-id-type="pmid">23260669</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levy</surname> <given-names>DN</given-names></name>, <name name-style="western"><surname>Aldrovandi</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Kutsch</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Shaw</surname> <given-names>GM</given-names></name>. <article-title>Dynamics of HIV-1 recombination in its natural target cells</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2004</year>;<volume>101</volume>(<issue>12</issue>):<fpage>4204</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0306764101" xlink:type="simple">10.1073/pnas.0306764101</ext-link></comment> <object-id pub-id-type="pmid">15010526</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meditz</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Haas</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Folkvord</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Melander</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Young</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>McCarter</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>HLA-DR+ CD38+ CD4+ T Lymphocytes Have Elevated CCR5 Expression and Produce the Majority of R5-Tropic HIV-1 RNA In Vivo</article-title>. <source>Journal of Virology</source>. <year>2011</year>;<volume>85</volume>(<issue>19</issue>):<fpage>10189</fpage>–<lpage>200</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/jvi.02529-10" xlink:type="simple">10.1128/jvi.02529-10</ext-link></comment> <object-id pub-id-type="pmid">21813616</object-id></mixed-citation></ref>
<ref id="ppat.1005924.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lahm</surname> <given-names>H-W</given-names></name>, <name name-style="western"><surname>Stein</surname> <given-names>S</given-names></name>. <article-title>Characterization of recombinant human interleukin-2 with micromethods</article-title>. <source>Journal of Chromatography A</source>. <year>1985</year>;<volume>326</volume>:<fpage>357</fpage>–<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0021-9673(01)87461-6" xlink:type="simple">10.1016/S0021-9673(01)87461-6</ext-link></comment> <object-id pub-id-type="pmid">3875623</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>